Biotechnology Books

Book SynopsisInvented by J. Monod, and independently by A. Novick and L. Szilard, in 1950, the chemostat is both a micro-organism culturing device and an abstracted ecosystem managed by a controlled nutrient flow. This book studies mathematical models of single species growth as well as competition models of multiple species by integrating recent work in theoretical ecology and population dynamics. Through a modeling approach, the hypotheses and conclusions drawn from the main mathematical results are analyzed and interpreted from a critical perspective. A large emphasis is placed on numerical simulations of which prudent use is advocated. The Chemostat is aimed at readers possessing degree-level mathematical knowledge and includes a detailed appendix of differential equations relating to specific notions and results used throughout this book. Table of ContentsIntroduction ix Chapter 1 Bioreactors 1 1.1. Introduction 1 1.1.1. What is a bioreactor? 1 1.1.2. Classification of biological reactors 2 1.1.3. A brief reminder of microbiology 3 1.2. Modeling of biological reactions 4 1.2.1. Regarding the state variables of the model 4 1.2.2. Biological processes and reaction scheme 8 1.2.3. Chemostat equations 11 1.2.4. Biological kinetics 14 1.2.5. The benefits of the chemostat 16 1.3. Toward “a little more” realism 17 1.3.1. Extensions 17 1.3.2. pH and physicochemical equilibria 20 1.3.3. Spatialization 22 1.3.4. Recent developments 23 Chapter 2 The Growth of a Single Species 25 2.1. Mathematical properties of the “minimal model” 26 2.1.1. General properties 26 2.1.2. The function μ is monotonic and bounded 29 2.1.3. The function μ is not monotonic 35 2.1.4. Interpretations 38 2.2. Simulations 40 2.2.1. Simulations in the phase space 41 2.2.2. Transients 43 2.3. Some extensions of the minimal model 45 2.3.1. Presence of biomass in the feed 46 2.3.2. Different dilutions 49 2.3.3. Density-dependent growth rate and characteristic at equilibrium 52 2.3.4. Yield depending on the density of the substrate 58 2.4. Bibliographic notes 61 Chapter 3 Competitive Exclusion 63 3.1. The case of monotonic growth functions 64 3.1.1. Steady states 64 3.1.2. Possible steady-states 65 3.1.3. Local stability of washout steady-state 66 3.2. Competitive exclusion at steady-state 67 3.2.1. Statement 68 3.2.2. Species at steady-state according to the dilution rate 68 3.2.3. Dynamics of proportions between species 69 3.2.4. Conclusion 73 3.3. Global stability 73 3.3.1. A “graphical” proof for two species 75 3.3.2. A proof for the general case 76 3.4. The case of non-monotonic growth functions 80 3.4.1. Growth set 81 3.4.2. Study of steady-states 82 3.4.3. Competitive exclusion 82 3.4.4. Competition between two species 83 3.4.5. Illustration and effect of a “bio-augmentation” 84 3.5. Bibliographic notes 88 Chapter 4 Competition: the Density-Dependent Model 93 4.1. Chapter orientation 93 4.2. Two-species competition 96 4.2.1. Behavior of an isolated species 97 4.2.2. Steady-state of two species in interaction 98 4.2.3. Steady-state stability 102 4.2.4. Simulations 103 4.3. N-species competition: exclusive intraspecific competition 104 4.3.1. Characteristic at equilibrium and coexistence 106 4.3.2. Simulations 110 4.4. N-species competition: the general case 111 4.4.1. A particular density-dependent model 112 4.4.2. Exclusive intraspecific competition 113 4.4.3. Dominant intraspecific competition 113 4.4.4. Undifferentiated competition 114 4.4.5. Dominant intraspecific competition 117 4.5. Bibliographic notes 123 Chapter 5 More Complex Models 125 5.1. Introduction 125 5.2. Models with aggregated biomass 126 5.2.1. Planktonic biomass versus aggregate biomass 127 5.2.2. Coexistence between the two forms 128 5.2.3. Coexistence steady-state 129 5.2.4. Stability study 133 5.2.5. The case of fast attachments/detachments 134 5.2.6. Consideration of several species 138 5.3. The “predator-prey” relationship in the chemostat 139 5.3.1. Introduction 139 5.3.2. The substrate-bacteria-predator “chain” 140 5.3.3. The substrate-bacteria-predators trophic network 143 5.3.4. Comparison to experimental data 146 5.4. Bibliographic notes 148 Appendices 151 Appendix 1 Differential Equations 153 Appendix 2 Indications for the Exercises 195 Bibliography 217 Index 225

Read more less

Book SynopsisOptimal control is a branch of applied mathematics that engineers need in order to optimize the operation of systems and production processes. Its application to concrete examples is often considered to be difficult because it requires a large investment to master its subtleties. The purpose of Optimal Control in Bioprocesses is to provide a pedagogical perspective on the foundations of the theory and to support the reader in its application, first by using academic examples and then by using concrete examples in biotechnology. The book is thus divided into two parts, the first of which outlines the essential definitions and concepts necessary for the understanding of Pontryagin’s maximum principle – or PMP – while the second exposes applications specific to the world of bioprocesses. This book is unique in that it focuses on the arguments and geometric interpretations of the trajectories provided by the application of PMP. Table of ContentsIntroduction ix Part 1 Learning to use Pontryagin’s Maximum Principle 1 Chapter 1 The Classical Calculus of Variations 3 1.1 Introduction: notations 3 1.2 Minimizing a function 4 1.2.1 Minimum of a function of one variable 4 1.2.2 Minimum of a function of two variables 6 1.3 Minimization of a functional: Euler–Lagrange equations 10 1.3.1 The problem 10 1.3.2 The differential of J 11 1.3.3 Examples 14 1.4 Hamilton’s equations 20 1.4.1 Hamilton’s classical equations 20 1.4.2 The limitations of classical calculus of variations and small steps toward the control theory 23 1.5 Historical and bibliographic observations 25 Chapter 2 Optimal Control 27 2.1 The vocabulary of optimal control theory 27 2.1.1 Controls and responses 27 2.1.2 Class of regular controls 28 2.1.3 Reachable states 31 2.1.4 Controllability 34 2.1.5 Optimal control 37 2.1.6 Existence of a minimum 38 2.1.7 Optimization and reachable states 42 2.2 Statement of Pontryagin’s maximum principle 44 2.2.1 PMP for the “canonical” problem 44 2.2.2 PMP for an integral cost 47 2.2.3 The PMP for the minimum-time problem 50 2.2.4 PMP in fixed terminal time and integral cost 52 2.2.5 PMP for a non-punctual target 56 2.3 PMP without terminal constraint 57 2.3.1 Statement 57 2.3.2 Corollary 59 2.3.3 Dynamic programming and interpretation of the adjoint vector 59 Chapter 3 Applications 65 3.1 Academic examples (to facilitate understanding) 65 3.1.1 The driver in a hurry 65 3.1.2 Profile of a road 67 3.1.3 Controlling the harmonic oscillator: the swing (problem) 70 3.1.4 The Fuller phenomenon 75 3.2 Regular problems 77 3.2.1 A regular Hamiltonian and the associated shooting method 77 3.2.2 The geodesic problem (seen as a minimum-time problem) 80 3.2.3 Regularization of the problem of the driver in a hurry 90 3.3 Non-regular problems and singular arcs 92 3.3.1 Optimal fishing problem 92 3.3.2 Discontinuous value function: the Zermelo navigation problem 102 3.4 Synthesis of the optimal control, discontinuity of the value function, singular arcs and feedback 118 3.5 Historical and bibliographic observations 125 Part 2 Applications in Process Engineering 127 Chapter 4 Optimal Filling of a Batch Reactor 129 4.1 Reducing the problem 130 4.2 Comparison with Bang–Bang policies 131 4.3 Optimal synthesis in the case of Monod 135 4.4 Optimal synthesis in the case of Haldane 135 4.4.1 Existence of an arc that (partially) separates Θ+ and Θ− 136 4.4.2 Using PMP 138 4.5 Historical and bibliographic observations 141 Chapter 5 Optimizing Biogas Production 143 5.1 The problem 143 5.2 Optimal solution in a well-dimensioned case 146 5.3 The Hamiltonian system 148 5.4 Optimal solutions in the underdimensioned case 156 5.5 Optimal solutions in the overdimensioned case 163 5.6 Inhibition by the substrate 167 5.7 Singular arcs 170 5.8 Historical and bibliographic observations 176 Chapter 6 Optimization of a Membrane Bioreactor (MBR) 177 6.1 Overview of the problem 177 6.2 The model proposed by Benyahia et al 185 6.3 The model proposed by Cogan and Chellamb 186 6.4 Historical and bibliographic observations 188 Appendices 191 Appendix 1 Notations and Terminology 193 Appendix 2 Differential Equations and Vector Fields 197 Appendix 3 Outline of the PMP Demonstration 205 Appendix 4 Demonstration of PMP without a Terminal Target 215 Appendix 5 Problems that are Linear in the Control 221 Appendix 6 Calculating Singular Arcs 231 References 237 Index 243

Read more less

Book SynopsisThe introduction of new technologies can be controversial, especially when they create ethical tensions as well as winners and losers among stakeholders and interest groups. While ethical tensions resulting from the genetic modification of crops and plants and their supportive gene technologies have been apparent for decades, persistent challenges remain. This book explores the contemporary nature, type, extent and implications of ethical tensions resulting from agricultural biotechnology specifically and technology generally. There are four main arenas of ethical tensions: public opinion, policy and regulation, technology as solutions to problems, and older versus new technologies. Contributions focus on one or more of these arenas by identifying the ethical tensions technology creates and articulating emerging fault lines and, where possible, viable solutions. Key features include: Focusing on contemporary challenges created by new and emerging technologies, especially agricultural biotechnology. Identifying a unique perspective by considering the problem of ethical tensions created or enhanced by new technologies. Providing an interdisciplinary perspective by including perspectives from sociologists, economists, philosophers and other social scientists. This book will be of interest to academics in agricultural economics, sociology and philosophy and policymakers concerned with introducing new technology into agriculture.Table of ContentsIntroduction: Ethical Tensions and New Technology: An Overview in the Context of Agricultural Biotechnology PART 1: PUBLIC OPINION AND INTEREST 1: Ethical Tensions from a ‘Science Alone’ Approach in Communicating Genetic Engineering Science to Consumers 2: Against the (GM) Grain: Ethical Tensions and Agrobiotechnology Activism in the USA 3: The Use and Abuse of the Term ‘GMO’ in the ‘Common Weal Rhetoric’ Against the Application of Modern Biotechnology in Agriculture 4: Collaborating with the Enemy? A View from Down Under on GM Research Partnerships PART 2: POLICY AND REGULATION 5: Three Models of Public Opinion and Public Interest for Agricultural Biotechnology: Precautionary, Conventional and Accommodative 6: Genetically Modified Organisms in Food: Ethical Tensions and the Labeling Initiative 7: Ethical Tensions in Regulation of Agricultural Biotechnology and their Impact on Policy Outcomes: Evidence from the USA and India PART 3: TECHNOLOGICAL FIX CRITICISM 8: Technological Pragmatism: Navigating the Ethical Tensions Created by Agricultural Biotechnology 9: Absolute Hogwash: Assemblage and the New Breed of Animal Biotechnology PART 4: NEW VERSUS OLD TECHNOLOGY 10: Nature-identical Outcomes, Artificial Processes: Governance of CRISPR/Cas Genome Editing as an Ethical Challenge 11: New Technology, Cognitive Bias and Ethical Tensions in Entrepreneurial Commercialization: The Case of CRISPR PART 5: MEDIATING ETHICAL TENSIONS 12: New Technology, Ethical Tensions and the Mediating Role of Translational Research

Read more less

Book SynopsisDescribing recent developments in the engineering and generation of plants as production platforms for biopharmaceuticals, this book includes both vaccines and monoclonal antibodies. It has a particular emphasis on targeting diseases which predominate in less developed countries, encompassing the current state of technologies and describing expression systems and applications. This book also includes a variety of vaccine case studies, protecting against pervasive infectious diseases such as rabies, influenza and HIV.Table of Contents1: Introduction, and the Promise of a Plant-derived Vaccine for Hepatitis B Virus 2: Protein Body-inducing Fusions for Recombinant Protein Production in Plants 3: Expression of Recombinant Proteins in Plant Cell Culture 4: Plant-derived Monoclonal Antibodies as Human Biologics for Infectious Disease and Cancer 5: Plant-produced Virus-like Particles 6: Expression of the Capsid Protein of Human Papillomavirus in Plants as an Alternative for the Production of Vaccines 7: Patenting of Plant-made Recombinant Pharmaceuticals and Access in the Developing World 8: Case Study 1: Rabies 9: Case Study 2: Plant-made HIV Vaccines and Neutralizing Antibodies 10: Case Study 3: The Search for a Plant-made Vaccine for Pandemic Influenza Virus

Read more less

Book SynopsisOil palm is the world's most important oil crop and crossing is used extensively in the production of commercial seed, breeding and genetic studies. This book illustrates crossing techniques to maximise success and safeguard purity, enabling the production of high quality seeds to grow-on as planting material and in breeding superior cultivars. Presenting sound practices based on scientific innovation in plant breeding, this guide provides techniques integrated with expertise and application of sustainable aspects of agronomy and crop protection, alongside information and imaging technology. Promoting green, eco-friendly agriculture, this book covers: biology and genetics, germplasm, target traits and commercial crossing; health and safety considerations in the field and laboratory; pollen collection and storage, pollen viability testing, and pollination; isolation of the female inflorescence; and commercial tenera production. Based on experience and protocols, this is an invaluable manual for students and researchers in agriculture, plant breeders, growers and end users interested in the practicalities of oil palm crossing for breeding and commercial seed productionTable of Contents1: Introduction 2: Health and Safety Considerations 3: Pollen Collection and Storage 4: Pollen Viability Testing 5: Isolation of the Female Inflorescence 6: Pollination 7: Commercial Tenera Production

Read more less

Book SynopsisThis is a practical guide to mutation breeding in oil palm, representing completely novel work supported by the Plant Breeding and Genetics Section of the Joint FAO/IAEA Division (Vienna, Austria). Oil palm is the top oil crop and the only major crop and only oil crop not to have been improved by plant mutation breeding. The manual is hands-on, providing step-by-step illustrated methods in mutation induction, mutation detection and mutant line development for oil palm improvement. Presenting sound practices based on scientific innovation and knowledge, this guide provides techniques integrated with expertise and is authored by practitioners actively engaged in oil palm seed production and breeding. Promoting green, eco-friendly agriculture, this book features coverage of: Radio-sensitivity testing Challenges and opportunities for mutation breeding Protocol for developing mutant generations for mutant screening Services in irradiation treatments The only available resource containing protocols and guidelines on how oil palm can be manipulated for mutation breeding, this book is essential reading for oil palm breeders, seed producers and plantation companies, oil palm traders, students and research institutes across the world. It provides a resource for training, a knowledge base for people new to oil palm and a reference guide for managers, to ensure best practices in maximising sustainability and production of this important crop. .Table of Contents1: Introduction 2: Health and Safety Considerations and Guidelines 3: Radio-sensitivity Testing 4: Options for Mutation Breeding in Oil Palm 5: Protocol for Developing Mutant Generations for Mutant Selection 6: Services in Irradiation Treatments

Read more less

Book SynopsisThis is a hands-on, practical guide covering seedling screening for disease response in oil palm for pathology, breeding and genetics. Oil palm is the top oil crop in the world and Ganoderma is the most devastating disease of oil palm. The authors are all actively engaged in oil palm seed production and breeding and bring together the many aspects of seedling disease testing in to one integrated manual. Presenting sound practices based on scientific innovation and knowledge, this guide provides techniques integrated with expertise and also looks towards future possibilities. Promoting green, eco-friendly agriculture, this book covers: Health and safety considerations Media preparation for in vitro culture Collecting isolates and culture preparation Preparation of Ganoderma inoculum Nursery inoculation Scoring response Based on experience and protocols, this is an invaluable manual for students and researchers in agriculture, plant breeders, growers, traders and production companies interested in the practicalities of oil palm pathology. It provides a resource for training, a knowledge base for people new to oil palm and a reference guide for managers, to ensure best practices in maximising sustainability and production of this important crop.Table of Contents1: Introduction 2: Health and Safety Considerations 3: Media Preparation for In Vitro Culture of Ganoderma 4: Collecting Ganoderma Isolates and Culture Preparation 5: Preparation of Ganoderma Inoculum 6: Nursery Inoculation 7: Scoring Response to Ganoderma 8: Future Possibilities

Read more less

Book SynopsisEndophytes are bacterial and fungal microorganisms that colonize plants without usually eliciting visible disease symptoms but establishing intricate and mutually beneficial interactions with their host plant. This can lead to an increase in plant vigour, growth, development, and changes in plant metabolism. Endophytes may assist in the development of more productive and sustainable agricultural practices or discoveries of novel pharmacologicals. These elusive organisms are often overlooked and their benefits underrated. Endophytes can support plants in a variety of ways to cope with biotic and abiotic stress factors, such as drought, heat, pest and diseases. They can produce particular metabolites, facilitate access to nutrients, change the plant's chemistry, physiology and responses, or by a combination of these factors. The biosynthetic pathways present in endophytes alone or in combinations with the plant's, can lead to novel chemicals, with yet undiscovered pharmacological characteristics. With state-of-the-art knowledge on their discovery and roles, this book describes the diversity of endophytes, their value, exploitation and future challenges. Key features: Provides an overview of the endophytes that are encountered in nature. Demonstrates the beneficial effects of endophytes together with their practical applications in agriculture. Explores how endophytes are valuable candidates for research on future drugs and biopesticides. This title is a valuable resource for students and researchers in plant science and plant pathology as well as those working in the pharmaceutical and pesticide industries.Table of ContentsChapter 1: Introduction. Chapter 2: Endophytic fungi: Definitions, diversity, distribution and their significance in plant life. Chapter 3: Sources, niches and routes of colonization by beneficial bacterial endophytes. Chapter 4: Analysing seed endophytes for biotechnology. Chapter 5: Mitigating Climate Impacts on Crop Production via Symbiosis. Chapter 6: Endophytes as novel pest control agents: myth or reality? Chapter 7: Improved adaptation of temperate grasses through mutualism with fungal endophytes. Chapter 8: Interactive effects of co-occurring epichloid endophytes, rhizobia and arbuscular mycorrhizal fungi modulating their benefits to grasses and legumes. Chapter 9: Saving resources: The exploitation of endophytes by plants for the biosynthesis of multifunctional defense compounds. Chapter 10: Bioprospecting of endophytes. Chapter 11: Prospects for biotechnological exploitation of endophytes using functional metagenomics. Chapter 12: Interplay between endophyte and host plant in the synthesis and modification of metabolites.

Read more less

Book SynopsisSince the first edition of this book was published in 2002, the field of quantitative genetics, genomics and breeding has changed markedly. In response, only four chapters have been updated for this new edition, and the remaining 16 chapters are entirely new. This book presents state-of-the-art, authoritative chapters on contemporary issues in the broad areas of quantitative genetics, genomics and plant breeding. Section 1 (Chapters 2 to 12) emphasizes the application of genomics, and genome and epigenome editing techniques, in plant breeding; bioinformatics; quantitative trait loci mapping; and the latest approaches of examining and exploiting genotype-environment interactions. Section 2 (Chapters 13 to 20) represents the intersection of breeding, genetics and genomics. This section describes the use of cutting-edge molecular breeding and quantitative genetics techniques in wheat, rice, maize, root and tuber crops and pearl millet. Overall, the book focuses on using genomic information to help evaluate traits that can combat biotic/abiotic stresses, genome-wide association mapping, high-throughput genotyping/phenotyping, biofortification, use of big data, orphan crops, and gene editing techniques. The examples featured are taken from across crop science research and cover a wide geographical base. This book contains: chapters by expert authors from six continents; state-of-the-art information on topical areas relative to crop improvement; coverage of genome-editing techniques.Table of Contents1: Vignettes of the History of Genetics Section I: Quantitative Genetics: Plant Breeding, Bioinformatics, Genome Editing and G × E Interaction 2: Food and Health: The Role of Plant Breeding 3: The Importance of Plant Pan-genomes in Breeding 4: Genome Editing Technologies for Crop Improvement 5: Epigenome Editing in Crop Improvement 6: Bioinformatics and Plant Breeding 7: Bioinformatics Approaches for Pathway Reconstruction in Orphan Crops — A New Paradigm 8: Advances in QTL Mapping and Cloning 9: Genotype–Environment Interaction and Stability Analyses: An Update 10: Biplot Analysis of Multi-environment Trial Data 11: Design and Analysis of Multi-year Field Trials for Annual Crops 12: Advances in the Definition of Adaptation Strategies and Yield-stability Targets in Plant Breeding Section II: Intersection of Breeding, Genetics and Genomics: Crop Examples 13: Prediction with Big Data in the Genomic and High-throughput Phenotyping Era: A Case Study with Wheat Data 14: Quantitative Genetics in Improving Root and Tuber Crops 15: Genomic Selection in Rice: Empirical Results and Implications for Breeding 16: Novel Breeding Approaches for Developing Climate-resilient Rice 17: Quantitative Genetics, Molecular Techniques and Agronomic Performance of Provitamin-A Maize in Sub-Saharan Africa 18: Developments in Genomics Relative to Abiotic Stress-tolerance Breeding in Maize During the Past Decade 19: Exploiting Alien Genetic Variation for Germplasm Enhancement in Brassica Oilseeds 20: Biofortified Pearl Millet Cultivars Offer Potential Solution to Tackle Malnutrition in India

Read more less

Book SynopsisThis is a hands-on, practical guide to describe physical bunch and oil analysis of oil palm. Bunch and oil analysis laboratories are set up at oil mills to assess production, yield potential of plantations and oil extraction rates relative to targets. The higher the oil yields produced by the planting material, the less land that is needed to achieve a specific level of production, hence helping in the sustainability of the crop. Practical, illustrated steps are given in determining bunch and oil characteristics of oil palm. Promoting green, eco-friendly agriculture, this book covers: An introduction to bunch and oil analysis Health and safety considerations Bunch sampling Physical bunch analysis of stalks, spikelets, fruits and nuts Fruit sampling Nut analysis and measurements of components Oil analysis, oil extraction and measurement Calculation of bunch components and reporting. This is an invaluable manual for oil palm mill managers, oil palm plantation managers, palm oil producers, oil palm breeders, agronomists, oil chemists, oil palm seed producing companies and research institutes across the world (especially tropical zones). It is useful for those starting a career in oil palm production, as a reference guide for managers and for training purposes.Table of Contents1: Introduction 2: Health and Safety Considerations 3: Bunch Sampling 4: Bunch Physical Analysis 5: Fruit Sampling 6: Nut Analysis 7: Oil Analysis 8: Recording, Calculations and Data Checks

Read more less

Book SynopsisThis is a hands-on, practical guide to describe field trials in oil palm breeding. Such trials are essential in almost all breeding programmes to select and verify the real expression of different target traits. In oil palm these include yield, tolerance to pests and diseases, oil quality and adaptability to the environment. Breeding success is dependent upon the genetic resources available and the effectiveness of screening amongst these for the desired traits. Many of these screens can now be carried out in the laboratory, particularly with DNA technologies. However, field trialing remains the "acid test" of commercial performance, with location and statistical design being key. Land preparation and the provision of good quality planting material, usually produced from deliberate cross-pollinations, underly the foundations of these trials. This book covers: Pre-trialing considerations and activities Land preparation Material preparation Trial planting Recording Ganoderma trials Pre-trial screening using DNA diagnostics This is an invaluable manual for oil palm breeders and oil palm institute across the world, and particularly tropical zones. It is also useful for those starting a career in oil palm improvement, those developing breeding programmes, as well as a reference guide for plantation managers and for training purposes.Table of Contents1: Introduction 2: Health and Safety Considerations 3: Pre-trialling Considerations and Activities 4: Land Preparation 5: Material Preparation 6: Trial Planting 7: Recording 8: Ganoderma Trials 9: Pre-trial Screening using DNA Diagnostics

Read more less

Book SynopsisThis is a hands-on practical guide to the use of Trichoderma as a biocontrol, as part of sustainable disease control measures for Ganoderma disease in oil palm plantations. The manual provides background information on Ganoderma (basal stem rot), the most devastating disease of oil palm in Southeast Asia, as well as on the benefits of Trichoderma fungi in safe guarding yields. The disease is caused by soil-borne fungi, Ganoderma spp, which are found in West Africa and South America, as well as Southeast Asia. Practical information is given on: the use of Trichoderma to manage Ganoderma for research and commercial use health and safety considerations in the laboratory, nursery and field in vitro multiplication of Trichoderma starting from media preparation and culture Ganoderma pathogenicity testing Trichoderma in vitro antagonism screening of Ganoderma Trichoderma screening to protect seedlings scoring Ganoderma response to Trichoderma in selecting aggressive Trichoderma isolates commercial use and application in oil palm plantations This is an invaluable manual for oil palm growers, estate/plantation managers, pathologists and breeders and research institutes across the world (especially tropical zones). It is also useful for those starting a career in oil palm plant protection, and as a reference guide for managers and for training purposes.Table of Contents1: Introduction 2: Health and Safety Considerations 3: Culturing Trichoderma 4: Trichoderma Multiplication 5: Ganoderma Pathogenicity Test 6: In Vitro Trichoderma Antagonism Screening 7: Trichoderma Nursery Screening for Ganoderma Control 8: Scoring Response of Ganoderma to Trichoderma 9: Preparation of Trichoderma for Commercial Application 10: Trichoderma Application in Oil Palm Plantations

Read more less

Book SynopsisThis is a hands-on, practical guide to general and specific practices in oil palm nurseries to produce healthy, vigorous and uniform plants ready for field planting. There are two nursery stages, pre-nursery and main nursery. The pre-nursery receives both germinated seeds and tissue culture produced plantlets (ramets) which are planted in a relatively small area in which shade and humidity can be controlled. Once young plants are established they are transferred to the main nursery, potted-on and grown on to produce field-ready plants. Good nursery practices, using sustainable approaches where possible, aim to provide high quality planting materials for both commercial production and field trialling. The book covers: Nursery set up - pre-nursery and main nursery Fertilizer programmes Watering Culling Weeding Pests and diseases Pre-field genotypic screening and selection Quarantine nurseries This is an invaluable manual for commercial seed producers, nursery plant producers, commercial plantation companies and plant breeders, as well as researchers in oil palm. It is useful for those starting a career in oil palm production, and as a reference guide for managers and for training purposes.Table of Contents1: Introduction 2: Health and Safety Considerations 3: Nursery Set-up 4: Pre-nursery Activities 5: Main Nursery Activities 6: Fertiliser Programmes 7: Watering 8: Culling 9: Weeding 10: Pests and Diseases 11: Pre-field Genotypic Screening and Selection 12: Quarantine Nurseries

Read more less

Book SynopsisMeeting future food needs without compromising environmental integrity is a central challenge for agriculture globally but especially for the Asia Pacific region - where 60% of the global population, including some of the world's poorest, live on only 30% of the land mass. To guarantee the food security of this and other regions, growers worldwide are rapidly adopting genetically modified (GM) crops as the forerunner to protect against many biotic and abiotic stresses. Asia Pacific countries play an important role in this, with India, China and Pakistan appearing in the top 10 countries with acreage of GM crops, primarily devoted to Bt cotton. Genetically Modified Crops in Asia Pacific discusses the progress of GM crop adoption across the Asia Pacific region over the past two decades, including research, development, adoption and sustainability, as well as the development and cultivation of insect protective Bt brinjal, drought-tolerant sugarcane, late blight resistant potato and biotech rice more specific to this region. Regulatory efforts of the Asia Pacific member nations to ensure the safety of GM crops to both humans and the environment are also outlined and discussed to provide impetus in other countries initiating biotech crops. The authors also probe into some aspects of gene editing and nanobiotechnology to expand the scope into next generation GM crops, including the potential to grow crops in acidic soil, reduce methane production, remove poisonous elements from plants and improve overall nutritional quality. Genetically Modified Crops in Asia Pacific provides a comprehensive reference not only for academics, researchers and private sectors in crop systems but also policy makers in the Asia Pacific region. Beyond this region, readers will benefit from understanding how GM crops have been integrated into many different countries and, in particular, the effects of the take-up of GM cropping systems by farmers with different socioeconomic backgroundsTable of Contents1: Biotech/genetically modified crops in Asia Pacific: a way forward 2: Economic and environmental impact of genetically modified crops in Asia Pacific 3: Development and commercialisation of Bt cotton in India 4: Insect resistance management for Bt cotton in India 5: Twenty years of successful Bt cotton production in Australia 6: Advances in managing insect resistance to Bt cotton in China 7: Bt cotton in Pakistan 8: Transgenic maize and its potential commercialisation in China 9: Bringing Bt eggplant to resource- poor farmers in Bangladesh and the Philippines 10: Adoption and advances in genetically modified oilseed crops in Australia 11: Bioefficacy testing of Bt corn against Asian corn borer in the Philippines 12: Insect resistance management of Bt corn in the Philippines 13: Socioeconomic and environmental impacts of GM corn in the ASEAN: the case of the Philippines 14: Biosafety management for genetically modified crops in Vietnam: from policy to practice 15: Biotechnology and its regulatory system in Japan 16: Development of yellow stem borer resistant rice varieties in Indonesia 17: Experience in developing genetically engineered potato resistant to late blight disease 18: Genetic modifications for disease resistance in crops 19: Nanobiotechnology for plant genome engineering and crop protection

Read more less

Book SynopsisThe year 2018 marked the 90th anniversary of induced mutagenesis in plants. The FAO/IAEA International Symposium on Plant Mutation Breeding and Biotechnology held in 2018 reviewed achievements in crop improvement through mutation breeding in several countries across the globe, and discussed innovations in mutation induction, precision phenotyping and genomics applications. Induced genetic variation is important for crop improvement especially in instances where there is limited variation in existing germplasm pools to achieve desired levels of crop performance, and where techniques such as hybridization cannot be easily applied. Its application becomes further significant as the dual threats of population growth and climate change increasingly challenge global food and nutrition security. Higher production of nutritional food and reduction of crop losses imposed by extreme events like droughts, high temperatures, floods, diseases and pests call for induced novel genetic variation. While recent breakthroughs in whole genome-based mutation detection technologies increase the efficiency and precision of breeding in all crops, in vitro techniques coupled with mutagenesis broaden the genetic base of vegetative and horticultural tree crops and reduce their breeding cycles. In this book an international team of expert authors review achievements, new developments, trends and challenges in the field of plant mutation breeding, across the scientific community and the private sector. Chapters highlight specific challenges, such as emerging transboundary threats to crop production, and assess the overall importance of mutation breeding to food security. Coverage includes: · Contribution and impact of mutant varieties to food security. · Mutation breeding for adaptation to climate change in seed propagated crops. · Mutation breeding for ornamental and vegetatively propagated crops. · Enhancing agro biodiversity through new mutation induction techniques. · New challenges and technologies in plant genomics and breeding. This book is a comprehensive and essential resource for students, researchers and professionals in plant breeding.Table of Contents1: Contribution of Crop Mutant Varieties to Food Security 1: World Food Supply: Problems and Prospects 2: Scandinavian Mutation Research During the Past 90 Years – a Historical Review 3: History of Mutation Breeding and Molecular Research Using Induced Mutations in Japan 4: Soybean Breeding Through Induced Mutation in Vietnam 5: New Mutation Techniques for Crop Improvement in China 6: High-yielding NERICA Mutant Rice for Upland Areas and Hope for Bangladeshi Farmers 7: Impact of Mutant Varieties in Malaysia: Challenges and Future Perspectives for Mutation Breeding 8: Application of Mutation Breeding Techniques in the Development of Green Crop Varieties in Sri Lanka: the Way Forward 9: Mutation Breeding in Rice for Sustainable Crop Production and Food Security in India 2: Mutation Breeding in Crop Improvement and Climate- Change Adaptation 10: Isolation and Characterization of Yellow Rust Resistant Mutants in Wheat 11: Identification of Rice Mutants Tolerant to Cold Stress at the Germination Stage by TILLING 12: Mutation Breeding of Sorghum to Support Climate-Smart Agriculture 13: Production of Haploid Embryos and Plants in Iranian Melon (Cucumis melo L.) Through Irradiated Pollen-induced Parthenogenesis 14: Application of Mutation Breeding to the Improvement of the Under-studied Crop Tef (Eragrostis tef (Zucc.) Trotter) 15: Improving Sustainable Cotton Production Through Enhanced Resilience to Climate Change Using Mutation Breeding 16: Development of Climate-Adaptable/ Resilient Crop Varieties Through Induced Mutation 17: Anthracnose Resistance Induction in Chilli by Electron Beam Irradiation

Read more less

Book SynopsisDespite their many common features (mechanical behavior, multi-scale structure, evolutionary and living characteristics, etc.), the tissues that make up the human body each have specific characteristics linked to their function, which require the development of dedicated experimental, theoretical and numerical methods. Mechanics of Living Tissues brings together the work of a number of experts to provide an overview of the most recent approaches developed to study the biomechanical behavior of these soft tissues, in order to understand their structure and apparent behavior. Specific tissues are analyzed across the chapters with the aim of developing solutions that address the clinical problems encountered. Conclusions are then drawn regarding future methods that will improve the current state of knowledge of the behavior of these living tissues, in particular with a view to predicting the effect of a pathology or medical procedure on their apparent properties.

Read more less

Book SynopsisThe Economics of Biotechnology is a highly accessible book dealing with some of the most crucial issues to arise in this area. Special attention is paid to consumer, ethical and environmental concerns as well as questions relating to trade policy, intellectual property, who will receive the benefits, international development and the role of international institutions such as the WTO.The authors examine concerns arising from the application of biotechnology in the agri-food industrial complex, and many of the issues discussed also have implications for the medical and pharmaceutical aspects of biotechnology.Fundamental questions regarding the application of standard economic analysis to biotechnology are resolved using traditional neo-classical analyses as well as less mainstream methods. Through exploring a number of approaches, original and unexpected conclusions are reached.This coherent and relevant treatment of the myriad facets of biotechnology will be welcomed by academics, scholars, and economists with a specific interest in international economics or technology, international policymakers, and economic commentators.Trade Review'The authors are to be commended for a timely book on the economics of agricultural biotechnology. . . Gaisford et al have provided a good starting point of particular relevance to economists who are seeking an initial conceptual perspective from which to comprehend the subject.' -- W. Lesser, Cornell University, US'The book does an excellent job at addressing all three levels from an efficiency and equity point of view . . . Readers with a background in biotechnology but less knowledge in economics will find it very useful, as well as economists who are interested in the key economic issues of biotechnology . . . I agree with the publisher that the addressed audience will welcome and like the book, and I can highly recommend it.' -- Justus Wesseler, European Review of Agricultural Economics'The book is an absorbing one . . . will give insight on business of biotechnology and related issues, such as ethical issues, IPR etc and to economist and market researchers with specified interest in biotechnology. This could be also useful for international policymakers/planners and economic commentators.' -- Ashok Pandey, Journal of Scientific and Industrial ResearchTable of ContentsContents: Preface 1. Biotechnology 2. Intellectual Property 3. The Environment 4. Consumer Issues 5. Ethical Concerns 6. Who Gets the Biotechnology Rents? 7. International Issues 8. Economics and the Future of Biotechnology References Index

Read more less

Book SynopsisHow will the industrial changes implicit within new biotechnologies affect modern agriculture? This book investigates these changes and provides an economic analysis of the industrial and distributional impacts of new biotechnologies, addressing in detail the significant consequences for developing countries.One of the most important facets of biotechnological change is the development of new technologies for appropriating the value of innovations in related industries. In agriculture these new appropriation technologies are known as 'genetic use restriction technologies', which enable the innovator to capture the value of innovative plant varieties by preventing their reproduction after purchase. This book analyses the implications of such technologies in terms of global agricultural production, the rate of innovation at the technological frontier and, in particular, the diffusion of these innovations across the globe. The authors set forth the economic and institutional framework within which innovations are occurring, focusing on the impacts on the least technologically advanced nations and their incentives to conserve genetic resources for use in future research and development.This stimulating book should be widely read by agricultural and resource economists, development economists, and scholars and researchers of environmental economics. Policymakers in developing countries will also gain valuable insights into the distribution of the potential benefits from biotechnology.Trade Review'. . . the volume offers many interesting calculations and insights.' -- Robert E. Evenson, Yale University, USTable of ContentsContents: Introduction 1. Biotechnologies and Developing Countries: How Will the Anticipated Industrial Changes in Agriculture Affect Developing Countries? Timothy Swanson PART I: SETTING THE SCENE: THE FRAMEWORK FOR CONSIDERING BIOTECHNOLOGY’S IMPACTS 2. Population Growth and Agricultural Intensification in Developing Countries Nadia Cuffaro 3. The Impacts of GURTs: Agricultural R&D and Appropriation Mechanisms Timothy Swanson and Timo Goeschl 4. Agricultural Biotechnology and Developing Countries: Proprietary Knowledge and Diffusion of Benefits Charles Spillane PART II: A CASE STUDY ON TERMINATORS: THE IMPACTS OF BIOTECHNOLOGIES ON BENEFIT DISTRIBUTION 5. The Impact of Terminator Gene Technologies on Developing Countries: A Legal Analysis William W. Fisher 6. Impact of Terminator Technologies in Developing Countries: A Framework for Economic Analysis C.S. Srinivasan and Colin Thirtle 7. The Impact of GURTs on Developing Countries: A Preliminary Assessment Timothy Swanson and Timo Goeschl 8. Forecasting the Impact of Genetic Use Restriction Technologies: A Case Study on the Impact of Hybrid Crop Varieties Timo Goeschl and Timothy Swanson PART III: BIOTECHNOLOGY AND BIODIVERSITY: THE IMPACTS OF BIOTECHNOLOGIES ON CONSERVATION OF GENETIC RESOURCES 9. Key Issues in Using Molecular Techniques to Improve Conservation and Use of Plant Genetic Resources Carmen de Vincente, Toby Hodgkin and Geoffrey Hawtin 10. Biotechnology and Traditional Breeding in Sub-Saharan Africa Vittorio Santaniello CONCLUSION 11. Policy Options for the Biotechnology Revolution: What Can be Done to Address the Distributional Implications of Biotechnologies? Timothy Swanson and Timo Goeschl Index

Read more less

Book SynopsisThe biotechnology industry across the globe is growing dramatically in line with rapidly emerging scientific and technological developments. This book explores both the theoretical and practical aspects of entrepreneurship in the biotechnology industry, focusing on the innovation processes underpinning success for new biotechnology firms (NBFs). It argues that biotechnology is at a crossroads: to date the science has been solid, yet commercial success remains elusive, and that it will be the commercial success of NBFs which will dictate the long term viability of this crucial industry.The authors go on to examine the roles played by both entrepreneurship and innovation in the competitiveness of biotechnology companies through a focus on: intellectual property strategies, product development, valuing biotechnology ventures, funding innovation and R&D, alliances and networking, changing industry structures evidenced through the shifting value chain and the impact of globalization on the changing industry and organizational life cycles. International case studies with a focus on human biosciences support the important theoretical developments at the heart of this book.Innovation and Entrepreneurship in Biotechnology offers original and valuable insights to researchers, academics and students as well as to practitioners involved with innovation and entrepreneurship in the field of biotechnology.Trade Review'This book is aimed at providing a large audience, including practitioners, politicians and decision-makers, with useful insights in relation to innovation and entrepreneurship in the biotechnology industry. It offers an international perspective and a set of theoretical lenses to underline the roles and the effects of entrepreneurship and scientific innovation as key factors to support new firm emergence and to achieve and maintain competitiveness in this so important industry.' -- Alain Fayolle, EM Lyon, CERAG Laboratory, France and Solvay Business School, BelgiumTable of ContentsContents: 1. Introduction: Innovation and Entrepreneurship 2. Entrepreneurship in the Biotechnology Context 3. Innovation and R&D Management 4. Funding Innovation in Biotechnology Companies 5. Intellectual Assets I – Intellectual Capital in Biotechnology Firms 6. Intellectual Assets II – Intellectual Gravity and Managing IP in Biotechnology Firms 7. The Cycle Game I – Product Life Cycle, R&D Cycle and Organizational Life Cycle 8. The Cycle Game II – Business, Market and Industry Cycles 9. Public Policy, Regulatory and Ethical Challenges Facing the Entrepreneurial Biotechnology Firm 10. The Biotechnology Value Chain 11. Biotechnology Industry and Firm Structures 12. Product Development and Innovation Diffusion 13. Biotechnology Industry Growth Models: An International Perspective Index

Read more less

Book SynopsisThis authoritative collection covers the economics and business side of the social scientific debate about the economics of 'modern biotechnology' or 'the biotechnology industry'. Biotechnology has attracted an enormous interest. Research has spawned work on a variety of theoretical issues about economic dynamics, about innovation systems and about what might be called - in the current jargon - the modern 'learning economy'. More generally, biotechnology is often perceived as one of the most important, broad, cutting-edge new technologies of the contemporary era. This collection will provide the reader with an accessible and structured understanding of the main issues which have characterized debates about the economics of biotechnology.Trade Review'. . . the selected contents make for a great leisurely read due to the breadth and the fluency of the various authors, and is thus generally recommended.' -- Iraj Daizadeh, Journal of Commercial Biotechnology'This book provides an invaluable introduction to the distinctive economic features of the biotechnology industry. Indeed, it is an introduction in more ways than one. To begin with, the 39 articles that make up the 2 volumes are the result of a thoughtful, judicious selection of the most influential contributions to the emergence and the maturation of this remarkable industry. At the same time, an introductory essay by the editors provides an indispensable reader's guide to the wide range of issues that have become especially salient along with the growth of the biotechnology industry: the costs and benefits of large vs. small firms; the benefits of vertical integration; the effectiveness of networks as a way of organizing the critical functions of R&D; the changing economics of the division of labor; the causes of geographical clustering; the relevance of the tacitness of knowledge; the impact of intellectual property rights, etc. The editors deserve to be congratulated for their endeavors in providing a book that should serve as an extremely useful research tool for a growing army of researchers. The book's usefulness is significantly enhanced by the fact that it draws upon a wide range of journals, many of which will not be readily accessible except at a very small number of the largest research universities. One can only admire the depth and the breadth of the research, on the part of the editors, that must have been involved in creating this invaluable research tool.' -- Nathan Rosenberg, Stanford University, US'An excellent collection of papers which are not only essential for the understanding of the biotechnology industry, but are also a must for students of industrial dynamics at large, of intellectual property rights, and of the economics and geography of innovation.' -- Giovanni Dosi, St Anna School of Advanced Studies, Pisa, ItalyTable of ContentsContents: Volume I Acknowledgements Preface Maureen McKelvey and Luigi Orsenigo Introduction Maureen McKelvey and Luigi Orsenigo PART I OVERVIEW 1. (1984), ‘Summary’ 2. Rebecca Henderson, Luigi Orsenigo and Gary P. Pisano (1999), ‘The Pharmaceutical Industry and the Revolution in Molecular Biology: Interactions Among Scientific, Institutional, and Organizational Change’ 3. Govindan Parayil (2003), ‘Mapping Technological Trajectories of the Green Revolution and the Gene Revolution from Modernization to Globalization’ 4. Hannah E. Kettler and Sonja Marjanovic (2004), ‘Engaging Biotechnology Companies in the Development of Innovative Solutions for Diseases of Poverty’ PART II SCIENCE AND INNOVATION 5. Ashish Arora and Alfonso Gambardella (1994), ‘Evaluating Technological Information and Utilizing It: Scientific Knowledge, Technological Capability, and External Linkages in Biotechnology’ 6. Gary P. Pisano (1994), ‘Knowledge, Integration, and the Locus of Learning: An Empirical Analysis of Process Development’ 7. Paul Nightingale (2000), ‘Economies of Scale in Experimentation: Knowledge and Technology in Pharmaceutical R&D’ 8. Michelle Gittelman and Bruce Kogut (2003), ‘Does Good Science Lead to Valuable Knowledge? Biotechnology Firms and the Evolutionary Logic of Citation Patterns’ 9. Maureen D. McKelvey (1996), ‘Introduction’ and ‘Conclusions for Science and Technology’ PART III NEW SPECIALISED BIOTECHNOLOGY FIRMS 10. Martin Kenney (1986), ‘Schumpeterian Innovation and Entrepreneurs in Capitalism: A Case Study of the U.S. Biotechnology Industry’ 11. David B. Audretsch (2001), ‘The Role of Small Firms in U.S. Biotechnology Clusters’ 12. Lynne G. Zucker, Michael R. Darby and Marilynn B. Brewer (1998), ‘Intellectual Human Capital and the Birth of U.S. Biotechnology Enterprises’ 13. Vincent Mangematin, Stéphane Lemarié, Jean-Pierre Boissin, David Catherine, Frédéric Corolleur, Roger Coronini and Michel Trommetter (2003), ‘Development of SMEs and Heterogeneity of Trajectories: The Case of Biotechnology in France’ PART IV REACTION AND ADAPTATION OF LARGE INCUMBENT COMPANIES 14. Louis Galambos and Jeffrey L. Sturchio (1998), ‘Pharmaceutical Firms and the Transition to Biotechnology: A Study in Strategic Innovation’ 15. Joanna Chataway, Joyce Tait and David Wield (2004), ‘Understanding Company R&D Strategies in Agro-Biotechnology: Trajectories and Blind Spots’ 16. Iain Cockburn and Rebecca M. Henderson (1998), ‘Absorptive Capacity, Coauthoring Behavior, and the Organization of Research in Drug Discovery’ 17. Lynne G. Zucker and Michael R. Darby (1997), ‘Present at the Biotechnological Revolution: Transformation of Technological Identity for a Large Incumbent Pharmaceutical Firm’ 18. Shyama V. Ramani (2002), ‘Who is Interested in Biotech? R&D Strategies, Knowledge Base and Market Sales of Indian Biopharmaceutical Firms’ Name Index Volume II Acknowledgements A preface and introduction by the editors to both volumes appears in Volume I PART I DIVISION OF LABOUR IN INNOVATIVE ACTIVITIES AND NETWORKS OF INNOVATORS 1. Gary P. Pisano (1991), ‘The Governance of Innovation: Vertical Integration and Collaborative Arrangements in the Biotechnology Industry’ 2. Ashish Arora and Alfonso Gambardella (1990), ‘Complementarity and External Linkages: The Strategies of the Large Firms in Biotechnology’ 3. Walter W. Powell, Kenneth W. Koput and Laurel Smith-Doerr (1996), ‘Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology’ 4. Julia Porter Liebeskind, Amalya Lumerman Oliver, Lynne Zucker and Marilynn Brewer (1996), ‘Social Networks, Learning, and Flexibility: Sourcing Scientific Knowledge in New Biotechnology Firms’ 5. Gordon Walker, Bruce Kogut and Weijian Shan (1997), ‘Social Capital, Structural Holes and the Formation of an Industry Network’ 6. Walter W. Powell, Douglas R. White, Kenneth W. Koput and Jason Owen-Smith (2005), ‘Network Dynamics and Field Evolution: The Growth of Interorganizational Collaboration in the Life Sciences’ 7. L. Orsenigo, F. Pammolli and Massimo Riccaboni (2001), ‘Technological Change and Network Dynamics: Lessons from the Pharmaceutical Industry’ PART II GEOGRAPHICAL AGGLOMERATION 8. David B. Audretsch and Paula E. Stephan (1996), ‘Company-Scientist Locational Links: The Case of Biotechnology’ 9. Maryann P. Feldman (2000), ‘Where Science Comes to Life: University Bioscience, Commercial Spin-offs and Regional Economic Development’ 10. Toby Stuart and Olav Sorenson (2003), ‘The Geography of Opportunity: Spatial Heterogeneity in Founding Rates and the Performance of Biotechnology Firms’ 11. Philip Cooke (2002), ‘Regional Innovation Systems: General Findings and Some New Evidence from Biotechnology Clusters’ 12. Jorge Niosi and Tomas G. Bas (2003), ‘Biotechnology Megacentres: Montreal and Toronto Regional Systems of Innovation’ PART III INSTITUTIONS SUPPORTING THE BIOTECHNOLOGY INDUSTRY 13. Martha Prevezer (2001), ‘Ingredients in the Early Development of the U.S. Biotechnology Industry’ 14. Steven Casper and Hannah Kettler (2001), ‘National Institutional Frameworks and the Hybridization of Entrepreneurial Business Models: The German and UK Biotechnology Sectors’ 15. Mark Lehrer and Kazuhiro Asakawa (2004), ‘Rethinking the Public Sector: Idiosyncrasies of Biotechnology Commercialization as Motors of National R&D Reform in Germany and Japan’ 16. Jason Owen-Smith, Massimo Riccaboni, Fabio Pammolli and Walter W. Powell (2002), ‘A Comparison of U.S. and European University-Industry Relations in the Life Sciences’ 17. Joel A.C. Baum and Brian S. Silverman (2004), ‘Picking Winners or Building Them? Alliance, Intellectual, and Human Capital as Selection Criteria in Venture Financing and Performance of Biotechnology Startups’ PART IV INTELLECTUAL PROPERTY 18. Michael A. Heller and Rebecca S. Eisenberg (1998), ‘Can Patents Deter Innovation? The Anticommons in Biomedical Research’ 19. Roberto Mazzoleni and Richard R. Nelson (1998), ‘The Benefits and Costs of Strong Patent Protection: A Contribution to the Current Debate’ 20. John P. Walsh, Ashish Arora and Wesley M. Cohen (2003), ‘Effects of Research Tool Patents and Licencing on Biomedical Innovation’ Name Index

Read more less

Book SynopsisBiotechnology has prompted a revolution in science and society in the truest sense of the word. For what superficially appears to be a revolution in biotechnology, in effect touches upon the fundamentals of life and the way in which humans relate to it. This book will make a significant contribution to the debate surrounding the effective regulation of biotechnology. The contributing authors assess how regulatory regimes can accommodate the many different and often conflicting issues to which biotechnology is giving rise to (including a very tainted public image). The book's ultimate aim is to explore ways of designing a regulatory regime that takes heed of these different demands whilst, at the same time, answering to the imperatives of effectiveness and efficiency.The book synthesizes three fields of legal analysis; the first focuses on the risk-dominated regulation of GM food and bio-agriculture; the second involves human genetics as a field dominated by considerations of ethics. Finally, patent law has been chosen as an area captured by notions of property.With its holistic approach, The Regulatory Challenge of Biotechnology will be of great interest to academics, policymakers and regulators as well as biotechnology and law students.Trade Review'. . . a compilation of 12 invaluable contributions on this issue by internationally known experts in their respective fields. . . a valuable resource for academic professionals, policy makers and legislators, advocacy groups and scholars in legal and development studies. It is a storehouse of learning and practical knowledge for anyone interested in environmental policy, biosafety issues, biotechnology processes and associated regulatory constraints.' -- Marcelin Tonye Mahop, Review of European Community and International Environmental Law'For bioethicists, legal scholars and regulators struggling with what controls to place on biotechnology, this is required reading.' -- John Avellanet, Journal of Commercial BiotechnologyTable of ContentsContents: Foreword PART I: GENERAL PERSPECTIVES ON BIOTECHNOLOGY REGULATION 1. Regulating Biotechnology: Lessons from Environmental Policy Neil Gunningham 2. Rethinking Regulatory Governance for the Age of Biotechnology Colin Scott PART II: REGULATING HUMAN GENETICS 3. Red Lights and Rogues: Regulating Human Genetics Roger Brownsword 4. An Abstract Approach to the Regulation of Human Genetics: Law, Morality and Social Policy Justine Burley PART III: GMOs AND AGRICULTURAL BIOTECHNOLOGY: REGULATING RISK 5. Constructing Risks: GMOs, Biosafety and Environmental Decision-Making Paul Street 6. Legal Framework and Political Strategy in Dealing with the Risks of New Technology: The Two Faces of the Precautionary Principle Wolfgang van den Daele 7. Regulating GM Food. Three Levels, Three Issues Bernd van der Meulen 8. Restrictions on the Cultivation of Genetically Modified Organisms: Issues of EC Law Sara Poli 9. A Tale of Two Commons: Plant Genetic Resources and Agricultural Trade Reform Mary E. Footer PART IV: REGULATING BIOTECHNOLOGY THROUGH THE PATENT SYSTEM 10. Should we Regulate Biotechnology through the Patent System? The Case of Terminator Technology Graham Dutfield 11. Patents, Patients and Consent: Exploring the Interface between Regulation and Innovation Regimes Graeme Laurie 12. Reshaping Bio-patents: Measures to Restore Trust in the Patent System Geertrui Van Overwalle Index

Read more less

Book SynopsisThis book offers a novel insight into the economic dynamics of modern biotechnology, using examples from Europe to reflect global trends. The authors apply theoretical insight to a fundamental enigma of the modern learning society, namely, how and why the development of knowledge and ideas interact with market processes and the formation of industries and firms. This book offers new empirical evidence to address such questions by studying the diversity of biotechnology in Europe. By analysing the way in which the development of new knowledge and information is linked with economic transformation, the authors are able to provide a rich theoretical understanding of the economic dynamics of knowledge within the biotechnology sector. They clearly show how innovation opportunities are affected not just by the market, but by scientific developments, networks, institutions and government policy. They also raise important theoretical questions about how and why new industries, networks and organizations are shaped, and highlight the development and impacts of biotechnology on many existing sectors, including pharmaceuticals, agriculture and insurance. The final chapter summarizes the theoretical challenges which have been overcome and identifies future areas for research.The Economic Dynamics of Modern Biotechnology will become essential reading for students, scholars and researchers of the management and economics of innovation, business strategy, industrial organization, the theory of the firm, the economics of technological change, and regional studies. It will also appeal to a wider political and business audience such as government policymakers and managers of biotechnology firms.Trade Review'All would agree that with more than 3,000 new firms formed in Europe, Japan and the United States focused on biotechnology, and with elegant strides forward in our understanding of genetics, the genome, proteomics and other related fields, a true intellectual, social and industrial revolution is in the making. Maureen McKelvey et al provide fascinating data on firm formation, case studies of emerging business models and cross-regional and national comparisons. The work is a useful beginning in our understanding of an emerging phenomenon.' -- James M. Utterback, Massachusetts Institute of Technology, US'This book is a highly ambitious work, the joint product of 25 co-authors. It represents an attempt to examine modern biotechnology as an economic process and, in so doing, it draws heavily - and successfully - upon the conceptual framework of evolutionary economics and the literature on industrial management. The empirical focus is on the present-day European scene, and it is a great virtue of the book that it unpacks and illuminates the diversity that characterizes that scene today. The wide coverage, along with the differing perspectives of individual authors, provides the reader with an invaluable platform for future research upon an industry that seems clearly destined to serve as an engine of economic growth in the new century.' -- Nathan Rosenberg, Stanford University, USTable of ContentsContents: Preface Part I: Introduction 1. Introduction Jens Laage-Hellman, Maureen McKelvey and Annika Rickne 2. Conceptualizing and Measuring Modern Biotechnology Johan Brink, Maureen McKelvey and Keith Smith Part II: Setting the Scene 3. Stylized Facts about Innovation Processes in Modern Biotechnology Maureen McKelvey, Annika Rickne and Jens Laage-Hellman 4. The Post-Genome Era: Rupture in the Organization of the Life Science Industry? Michel Quéré 5. An Overview of Biotechnology Innovation in Europe: Firms, Demand, Government Policy and Research Jacqueline Senker Part III: Challenging the Existing 6. Risk Management and the Commercialization of Human Genetic Testing in the UK Michael M. Hopkins and Paul Nightingale 7. Network and Technology Systems in Science-driven Fields: The Case of European Food Biotechnology Finn Valentin and Rasmus Lund Jensen 8. Future Imperfect: The Response of the Insurance Industry to the Emergence of Predictive Genetic Testing Stefano Brusoni, Rachel Cutts and Aldo Geuna 9. Emergent Bioinformatics and Newly Distributed Innovation Processes Andrew McMeekin, Mark Harvey and Sally Gee Part IV: Forming the New 10. The Dynamics of Regional Specialization in Modern Biotechnology: Comparing Two Regions in Sweden and Two Regions in Australia, 1977–2001 Johan Brink, Linus Dahlander and Maureen McKelvey 11. On the Spatial Dimension of Firm Formation Annika Rickne 12. Examining the Marketplace for Ideas: How Local are Europe’s Biotechnology Clusters? Steven Casper and Fiona Murray 13. Creation and Growth of High-Tech SMEs: The Role of the Local Environment Corinne Autant-Bernard, Vincent Mangematin and Nadine Massard Part V: Conclusions 14. Reflections and Ways Forward Hannah Kettler, Maureen McKelvey and Luigi Orsenigo Index

Read more less

Book SynopsisIt has been recognized that an important factor in improving the viability of rural livelihoods in developing countries is the promotion of sustainable agriculture. As opposed to relying solely on cash crops, this can be more easily achieved through the domestication of various indigenous fruit trees that can be cultivated and owned by smallholder farmers. Through multi-functional and integrated farming systems, these tree crops can support environmental and social sustainability by providing food as well as promoting economic growth. Twenty years ago, little was known about the biology, ecology or the social impact of indigenous fruit trees on rural populations. Since then, new concepts and approaches have been developed, case studies have been produced and the potential and feasibility of their domestication and commercialization has been explored. This focused study on the tropics brings together a comprehensive review of this research.Table of ContentsPART 1: SETTING THE SCENE 1: Setting priorities among indigenous fruit tree species in Africa: Examples from southern, eastern and western Africa regions 2: Towards domestication strategy for indigenous fruit trees in the tropics 3: Challenges to stimulating the adoption and impact of indigenous fruit trees in tropical agriculture PART II: INDIGENOUS FRUIT TREE DOMESTICATION IN ASIA, LATIN AMERICA and OCEANIA 4: Domestication of trees or of forests: development pathways for fruit tree production in southeast Asia 5: Homegarden-based indigenous fruit tree production in peninsular India 6: Native fruit tree improvement in Amazonia: an overview 7: The domestication of fruits and nut trees species in Vanuatu, Oceania PART III: REGIONAL DOMESTICATION RESEARCH AND DEVELOPMENT IN AFRICA 8: Creating opportunities for domesticating and commercializing miombo indigenous fruit trees in Southern Africa 9: Domestication, utilisation and marketing of indigenous fruit trees: Experiences from West and Central Africa 10: Strengthening rural livelihoods through domestication of indigenous fruit trees in the parklands of the Sahel 11: The role of indigenous fruit trees in sustainable dryland agriculture in Eastern Africa PART IV: THE BIOPHYSICAL AND SOCIOECONOMIC CONTEXT OF MIOMBO FRUIT TREES 12: Marketing of indigenous fruits in southern Africa 13: Economics of on-farm production of indigenous fruits 14: Opportunities for commercialization and enterprise development of indigenous fruits in southern Africa 15: The feasibility of small-scale indigenous fruit processing enterprises in Southern Africa 16: Product development: nutritional value, processing and utilization of indigenous fruits from the miombo ecosystem 17: Germplasm, propagation and nursery management of miombo fruit trees 18: Pest management in high commercial value indigenous fruit trees PART V: LESSONS FOR COMODITIZING INDIGENOUS FRUIT TREES AND NUTS IN THE TROPICS 19: Accelerated domestication and commercialization of indigenous fruit and nut trees to enhance better livelihoods in the tropics: Lessons and way forward

Read more less

Book SynopsisScientists are becoming progressively more involved in developing methods for increasing agricultural productivity and designing plants with certain qualities. As such, genetic engineering has given plant breeders a means to exercise property rights over different varieties of plants. This has created many implications and given way to much controversy, with most objections being raised against the idea of owning life. With the use of comparative studies, this book discusses the legal, agribusiness and public policy issues that connect intellectual property protection with advancements in agricultural biotechnology.Table of Contents1: Patented Inventions and Externalities: Hohfeldian Legal Relationships AsThey Apply to Pollen Drift and Other Inadvertent Use 2: Insecure Property Rights and Plant Varieties 3: The Effects on the Market for Seeds and on Farmers in Argentina 4: Rules v. Standards for Patent Law in the Plant Sciences 5: The regulatory regime and its impact on innovation activities in agro-food biotechnology in the EU and USA 6: Agricultural Biotechnology under Trips and Beyond: Addressing Social Policies in a Pro-Patent Environment 7: The Impact of Intellectual Property Rights in the Plant/Seed Industry 8: Constitutional Implications of State Seed Saving Statutes 9: Dynamic Pricing Mechanism to Achieve Pareto Optimality in a Seed Production Contract 10: Access and Equity in Trade Negotiations on Knowledge Resources 11: Public Provision of Knowledge for Policy Research: The Agricultural Biotechnology Intellectual Property Database 12: An Economic Comparison of the Incentive to Innovate under Patents and Plant Breeders’ Rights 13: The Political Economy of Intellectual Property: 14: Re-Examining European Policy on Plant Biotechnology 15: Legal Constraint of Genetic Use Restriction Technologies 16: The Strength and Structure of Intellectual Bio-Property Markets 17: Network Analysis for Interpreting Patent Date: A Preliminary, Visual Approach 18: Reality and Problems of Plant Protection under Patent Law and Seed and Seeding Law in Japan 19: Running Head: Plant Variety Protection in the Republic of Korea 20: To Sow or Not to Sow:Dilemmas in Creating New Rights in Food

Read more less

Book SynopsisSince the publication of Plant Genotyping: the DNA Fingerprinting of Plants in 2001, the techniques available for plant DNA analysis have advanced considerably. Recent developments focus on high throughput methods, and generally target single nucleotide polymorphism (SNP) discovery and analysis. SNPs represent the most common form of genetic variation in both plants and animals, and play a key role in revealing the molecular mechanisms underlying traits. Plant Genotyping II: SNP Technology describes some of the import recent developments in this field, with the main focus on SNPs. Contributions cover the discovery, analysis and uses of SNPs, while also examining other approaches to plant genotyping.Table of Contents1: SNP Discovery in Plants 2: SNPs and Their Use in Maize 3: Rare SNP Discovery with Endonucleases 4: Sequence Polymorphisms in the Flanking Regions of Microsatellite Markers 5: SNP Discovery by Ecotilling Using Capillary Electrophoresis 6: Genotyping by Allele Specific PCR 7: The MassARRAY® System for Plant Genetics 8: Mutation Screening

Read more less

Book SynopsisThere have been rapid advances in the field of plant biotechnology in recent years, increasing the potential for medical application. Covering the latest advances in the use of plants to produce medicinal drugs and vaccines, this volume examines topics including plant tissue culture, secondary metabolite production, metabolomics and metabolic engineering, bioinformatics, molecular farming and future biotechnological directions, with contributors from key researchers in the field. Medicinal Plant Biotechnology is an essential text for researchers in plant biology and biotechnology, medical sciences and pharmacology.Table of Contents1: Emerging Trends in Medicinal Plant Biotechnology 2: Medicinal Compounds Produced in Plant Cell Factories 3: Biotechnological Characterization of Populations of Podophyllum hexandrum Royle. 4: Traditional and Biotechnological Strategies for Conservation of Podophyllum hexandrum Royle 5: Microsatellite Markers: Potential and Opportunities in Medicinal Plants 6: In vitro-Propagation of Medicinal Plants for Conservation and Quality Assurance 7: Propagation of elite Cannabis sativa L. for the production of 9-Tetrahydrocannabinol (THC) 8: In Vitro Saponin Production in Plant Cell And Tissue Cultures 9: Podophyllotoxin and Related Lignans: Biotechnological Production by In Vitro Plant Cell Cultures 10: Hairy Root Culture: Copying Nature in New Bioprocesses 11: Genetic Transformation of Catharanthus roseus (L.) G. Don. for Augmenting Secondary Metabolite Production 12: Podophyllum Endophytic Fungi 13: Biotechnology of Vinca major and Vinca minor 14: Analytical Platforms and Databases from Plant Transcriptomics to Metabolomics 15: Docking-based Virtual Screening of Anticancer Drugs 16: Population Structure and Molecular Characterization of Podophyllum hexandrum 17: Plant Virus Vector Systems for the Production and Delivery of Biopharmaceuticals 18: Novel Medicinal Plants for the Production and Delivery of Vaccines 19: Noscapinoids: A New Class of Anti-cancer Drugs Demand Biotechnological Intervention 20: Recent Developments in Chemistry and Biotechnology of Podophyllum 21: Plant-derived Recombinant Griffithsin 22: Camptothecins: SAR, QSAR, and Biotechnology

Read more less

Book SynopsisAt a time when the world's food supplies are increasingly unable to meet the needs of a burgeoning population, the subject matter of this book has never been more relevant. At the same time, there is significant diversity of opinion concerning the benefits and perceived dangers of the applications of biotechnology in food production. To help inform this debate, the aim of Plants, Biotechnology & Agriculture is to provide the reader with a comprehensive yet concise overview of plants as both biological organisms and useful resources for people to exploit. The first half of the book gives a basic overview of plant biology including how plants develop and respond to their environment, acting as a primer for those without a biology background and a refresher for students of plant biology and agriculture. These chapters set the scene for an outline of human exploitation of plants, from domestication to scientific manipulation. The complex technologies now being applied to improving crops are then described, guiding the reader through the extensive terminologies and jargon, using focus boxes to illustrate key processes and issues. The final two chapters address society's response to biotechnology, how these technologies are being modified in response to public concerns, and new technologies being developed to meet the challenges of rapid population growth, depletion of non-renewable resources and climate change.Table of ContentsPart I: Plants and their Genomes 1: Plants and their Exploitation by People 2: Photosynthesis and the Evolution of Plants 3: Plant Molecular Genetics and Genomics Part II: How Plants Function 4: Plant Metabolism 5: Plant Organization and Development 6: Plant Responses to the Environment Part III: How Plants are Manipulated 7: Domestication and the Empirical Exploitation of Plants 8: The Scientific Manipulation of Plants 9: Crop Improvement in the 20th Century Part IV: Plants, Society and the Future 10: Plant Biotechnologies in the 21st Century 11: Social Context of Plant Biotechnologies 12: Future Challenges for Plant Biotechnology

Read more less

Book SynopsisAt a time when the world's food supplies are increasingly unable to meet the needs of a burgeoning population, the subject matter of this book has never been more relevant. At the same time, there is significant diversity of opinion concerning the benefits and perceived dangers of the applications of biotechnology in food production. To help inform this debate, the aim of Plants, Biotechnology & Agriculture is to provide the reader with a comprehensive yet concise overview of plants as both biological organisms and useful resources for people to exploit. The first half of the book gives a basic overview of plant biology including how plants develop and respond to their environment, acting as a primer for those without a biology background and a refresher for students of plant biology and agriculture. These chapters set the scene for an outline of human exploitation of plants, from domestication to scientific manipulation. The complex technologies now being applied to improving crops are then described, guiding the reader through the extensive terminologies and jargon, using focus boxes to illustrate key processes and issues. The final two chapters address society's response to biotechnology, how these technologies are being modified in response to public concerns, and new technologies being developed to meet the challenges of rapid population growth, depletion of non-renewable resources and climate change.Table of ContentsPart I: Plants and their Genomes 1: Plants and their Exploitation by People 2: Photosynthesis and the Evolution of Plants 3: Plant Molecular Genetics and Genomics Part II: How Plants Function 4: Plant Metabolism 5: Plant Organization and Development 6: Plant Responses to the Environment Part III: How Plants are Manipulated 7: Domestication and the Empirical Exploitation of Plants 8: The Scientific Manipulation of Plants 9: Crop Improvement in the 20th Century Part IV: Plants, Society and the Future 10: Plant Biotechnologies in the 21st Century 11: Social Context of Plant Biotechnologies 12: Future Challenges for Plant Biotechnology

Read more less

Book SynopsisInnovation and Liability in Biotechnology introduces and articulates an innovative framework, the Liability Analysis Framework (LAF), which offers a new perspective from which stakeholders and society can assess, manage and communicate about liability in relation to innovation. This path-breaking book provides a detailed description of the relationship between risk and liability. Risk and liability are not synonymous and the fact that, at times, the terms have been used in very close proximity has resulted in confusion and misunderstandings. The book begins with an overview of risk and the development of the Risk Analysis Framework, describing how it has evolved from initial concepts to present day form. It highlights the need for a LAF and provides a diverse examination of the LAF as a means to stimulate further debate. The authors conclude that risk is concerned with hypothetical probabilities whereas liability relates to actual marketplace externalities.Offering a new conceptualization for the analysis of liability, this book will appeal to academics involved in the fields of law, innovation and business, as well as federal regulators and industry representatives. Agricultural organizations and their lawyers who are attempting to understand the legal liability issues involved in growing and marking transgenic crops and their products, will also find this book of great interest.Trade Review'If only one thing could be said about this book is that it comes at the perfect time and fills a great void on the subject it addresses. Genetically Modified Organisms are innovative - so have to be the answers to the legal questions raised by their development: What should be the definition of damage? Who should be held liable? Where should claims be brought? The Parties to the Cartagena Protocol on Biosafety have been discussing these issues for many years and are now ready to give some answers by means of a new multilateral environmental treaty. The comprehensive analysis and comparative data put forth by the authors contribute enormously to the current debate and provide detailed insights into the nuances of international liability in a manner previously unaddressed.' -- Jimena Nieto Carrasco, University of the Andes, El Rosario University, Externado University of Colombia, Bogota, ColombiaTable of ContentsContents: Preface Part I: Introduction 1. Transitioning from the Risk Analysis Framework to a Liability Analysis Framework Part II: Liability Assessment 2. Liability Regimes in North America 3. European Liability Regimes 4. International Economic Liability Regimes Part III: Liability Management 5. Patent Policy’s Interface with Regulation and Liability 6. Coexistence Strategies and Industrial Stewardship 7. Non-adopter Liabilities Within the Agri-food Industry Part IV: Liability Communication 8. Improving Consumer Confidence 9. Regulatory Strategies for Innovative Technologies and Liability for Plant Molecular Farming Part V: Agriculture, Liability and the Future 10. Synopsis and Important Issues Bibliography Index

Read more less

Book SynopsisThe biotechnology industry across the globe is growing dramatically in line with rapidly emerging scientific and technological developments. This book explores both the theoretical and practical aspects of entrepreneurship in the biotechnology industry, focusing on the innovation processes underpinning success for new biotechnology firms (NBFs). It argues that biotechnology is at a crossroads: to date the science has been solid, yet commercial success remains elusive, and that it will be the commercial success of NBFs which will dictate the long term viability of this crucial industry.The authors go on to examine the roles played by both entrepreneurship and innovation in the competitiveness of biotechnology companies through a focus on: intellectual property strategies, product development, valuing biotechnology ventures, funding innovation and R&D, alliances and networking, changing industry structures evidenced through the shifting value chain and the impact of globalization on the changing industry and organizational life cycles. International case studies with a focus on human biosciences support the important theoretical developments at the heart of this book.Innovation and Entrepreneurship in Biotechnology offers original and valuable insights to researchers, academics and students as well as to practitioners involved with innovation and entrepreneurship in the field of biotechnology.Trade Review'This book is aimed at providing a large audience, including practitioners, politicians and decision-makers, with useful insights in relation to innovation and entrepreneurship in the biotechnology industry. It offers an international perspective and a set of theoretical lenses to underline the roles and the effects of entrepreneurship and scientific innovation as key factors to support new firm emergence and to achieve and maintain competitiveness in this so important industry.' -- Alain Fayolle, EM Lyon, CERAG Laboratory, France and Solvay Business School, BelgiumTable of ContentsContents: 1. Introduction: Innovation and Entrepreneurship 2. Entrepreneurship in the Biotechnology Context 3. Innovation and R&D Management 4. Funding Innovation in Biotechnology Companies 5. Intellectual Assets I – Intellectual Capital in Biotechnology Firms 6. Intellectual Assets II – Intellectual Gravity and Managing IP in Biotechnology Firms 7. The Cycle Game I – Product Life Cycle, R&D Cycle and Organizational Life Cycle 8. The Cycle Game II – Business, Market and Industry Cycles 9. Public Policy, Regulatory and Ethical Challenges Facing the Entrepreneurial Biotechnology Firm 10. The Biotechnology Value Chain 11. Biotechnology Industry and Firm Structures 12. Product Development and Innovation Diffusion 13. Biotechnology Industry Growth Models: An International Perspective Index

Read more less

Book SynopsisStarting with the 13th century, this book explores how patents have been used as an economic protectionist tool, developing and evolving to the point where thousands of patents have been ultimately granted not over inventions, but over isolated or purified biological materials. DNA, invented by no man and once thought to be 'free to all men and reserved exclusively to none', has become cartelised in the hands of multinational corporations. The author questions whether the continuing grant of patents can be justified when they are now used to suppress, rather than promote, research and development in the life sciences.Luigi Palombi demonstrates that patents are about inventions and not isolated biological materials, which consequently have no bona fide purpose in the innovations of biotechnological science. This book will be important reading for anyone who has an interest in the role that patents have played in economic development - particularly historians, economists and scientists. It will also be of great interest to law academics, lawyers, judges and policymakers.Trade Review'Palombi has penned a strong critique of the abuse of the patent system by the biotech industry in its pursuit of monopoly rights over natural organisms and their parts and, in particular, over fragments of DNA. He argues that it is difficult to recognise such ownership as reflecting genuine novelty of human inventiveness. He shows through detailed exposition and analysis of cases how the patent system has been appropriated (in his words) to serve the interests of a narrow group of biotech, pharma and chemical interests; his book will serve as a clear statement as to why this is so damaging to real innovation and progress in a range of health-related topics.' -- John A. Mathews, Review of International Political Economy'It's really excellent: an invaluable source of information and highly readable too.' -- Sir John Sulston, University of Manchester, UK and Winner of the 2002 Nobel Prize in Physiology or Medicine'. . . this is a book that every policymaker even remotely connected to issues of patents, economics, and biotech should read. This book is essential ammunition for those who oppose gene patenting, and lays out the legal case expertly.' -- David Koepsell, Delft University of Technology, The Netherlands, reviewed in SCRIPTed'The book is of interest to judges, patent attorneys and lawyers and policy-makers in this field. . . The first part is a fascinating and well researched historical study of patenting. . . The second part of the book is interesting and the author raises some very important points. . . a very valuable contribution to the debate of the scope of patent monopolies.' -- David Rogers, Legal Member, Boards of Appeal, European Patent Office, Germany, reviewed in European Intellectual Property ReviewTable of ContentsContents: Foreword by Baruch S. Blumberg Preface Part I: Monopolies in the Age of Free Trade 1. The Early History of Anglo-American Patent Systems 2. Patents and their Use in Economic Warfare 3. Patent Monopolies versus Free Trade 4. The Patent Systems of Continental Europe 5. The Internationalization and Harmonization of the Patent Systems Part II: The Patenting of Biological Materials: The Monopolization of Nature 6. The Isolation Contrivance 7. Anything Under the Sun Made by Man 8. The Invention of Nature? 9. Gene Wars 10. Synthetic Biology and a Time for Reflection Bibliography Index

Read more less

Book SynopsisThis fascinating study describes efforts to define and protect traditional knowledge and the associated issues of access to genetic resources, from the negotiation of the Convention on Biological Diversity to The Declaration on the Rights of Indigenous Peoples and the Nagoya Protocol. Drawing on the expertise of local specialists from around the globe, the chapters judiciously mix theory and empirical evidence to provide a deep and convincing understanding of traditional knowledge, innovation, access to genetic resources, and benefit sharing. Because traditional knowledge was understood in early negotiations to be subject to a property rights framework, these often became bogged down due to differing views on the rights involved. New models, developed around the notion of distributive justice and self-determination, are now gaining favor. This book suggests - through a discussion of theory and contemporary case studies from Brazil, India, Kenya and Canada - that a focus on distributive justice best advances the interests of indigenous peoples while also fostering scientific innovation in both developed and developing countries. Comprehensive as well as nuanced, Genetic Resources and Traditional Knowledge will be of great interest to scholars and students of law, political science, anthropology and geography. National and international policy makers and those interested in the environment, indigenous peoples' rights and innovation will find the book an enlightening resource. Contributors: T. Bubela, J. Carbone, R. Crookshanks, L. DeBusschere, G. Dutfield, E.R. Gold, D.S. Hik, A. Kumbamu, C. Lawson, C. Metcalf, S. Nickels, K. Nnadozie, P.W.B. Phillips, E.B. Rodrigues Jr, T. Williams, S. ZhangTable of ContentsContents: 1. Introduction: Indigenous Rights and Traditional Knowledge Tania Bubela and E. Richard Gold PART I: THE INTERNATIONAL LEGAL AND POLITICAL LANDSCAPE 2. WIPO, Genetic Resources and TK: The Evolution of a Formal Intellectual Property Agreement Protecting TK Associated with Genetic Resources Charles Lawson 3. A Comparative Analysis of Access and Benefits-Sharing Systems Rebecca Crookshanks and Peter W.B. Phillips 4. From Traditional Medicines to Modern Drugs Graham Dutfield PART II: CASE STUDIES Brazil 5. Property Rights, Biocultural Resources and Two Tragedies: Some Lessons from Brazil Edson Beas Rodrigues Jr Kenya 6. Old Wine in New Skin: Traditional Knowledge and Customary Law Under the Evolving Normative Environment in Kenya Kent Nnadozie India 7. Sustaining the Indigenous Knowledge Commons Ashok Kumbamu Canada 8. Canada’s First Nations’ Policies and Practices Related to Managing Traditional Knowledge Peter W.B. Phillips, Sidi Zhang, Tara Williams and Laural DeBusschere 9. Aboriginal Rights and Traditional Ecological Knowledge in Northern Canada Cherie Metcalf and Tania Bubela 10. Respecting and Aligning Knowledge Systems in Northern Canada: Beyond the International Polar Year David S. Hik, Tania Bubela and Scot Nickels PART III: CONCLUSION 11. A Capabilities-based Framework Julia Carbone Index

Read more less

Book SynopsisIn this timely title Professor Arti Rai brings together a wide range of articles that reveal the important role of intellectual property law in the formation and development of the dynamic and economically significant biotechnology industry. The collection encompasses theoretical articles that present principles of patent economics important to the industry, articles that discuss the patent law doctrines most relevant to biotechnology and empirical studies on the 'real world' effects of patents and secrecy. These are resonant issues in an ever-expanding field, and will establish this book as an essential reference point for lawyers, researchers and students.Trade Review‘Arti Rai is a wise and pithy scholar of patent jurisprudence. She is an insightful futurist of intellectual property, showing great insight about the implications of new technologies – such as information technology, biotechnology, pharmacogenomics, and synthetic biology. Arti Rai is also a lucid and persuasive advocate of the necessity for patent law reform. This authoritative and carefully researched volume will be essential reading.’ -- Matthew Rimmer, The Australian National UniversityTable of ContentsContents: Acknowledgements Introduction Arti K. Rai PART I THE LAW AND ECONOMICS OF BIOTECHNOLOGY PATENTS: FIRST PRINCIPLES A. Foundational Technologies 1. Edmund W. Kitch (1977), ‘The Nature and Function of the Patent System’ 2. Robert P. Merges and Richard R. Nelson (1990), ‘On the Complex Economics of Patent Scope’ B. Anti-commons 3. Michael A. Heller and Rebecca S. Eisenberg (1998), ‘Can Patents Deter Innovation? The Anti Commons in Biomedical Research’ 4. John P. Walsh, Ashish Arora and Wesley M. Cohen (2003), ‘Working Through the Patent Problem’ 5. Fiona Murray and Scott Stern (2007), ‘Do Formal Intellectual Property Rights Hinder the Free Flow of Scientific Knowledge? An Empirical Test of the Anti-commons Hypothesis’ 6. Chris Holman (2006) ’Clearing a Path Through the Patent Thicket’ C. Patents and Industrial Organization 7. Ashish Arora and Robert P. Merges (2004), ‘Specialised Supply Firms, Property Rights and Firm Boundaries’ PART II ADDRESSING TRANSACTION COSTS: THE ROLE OF THE UTILITY REQUIREMENT 8. John M. Golden (2001), ‘Biotechnology, Technology Policy, and Patentability: Natural Products and Invention in the American System’ PART III THE ROLE OF INSTITUTIONS: BIOTECHNOLOGY PATENTS AND THE FEDERAL CIRCUIT 9. Arti K. Rai (1999), ‘Intellectual Property Rights in Biotechnology: Addressing New Technology’ 10. Dan L. Burk and Mark A. Lemley (2002), ‘Is Patent Law Technology-Specific?’ PART IV PATENTABLE SUBJECT MATTER 11. Kevin Emerson Collins (2007), ‘Propertizing Thought’ PART V EXPERIMENTAL USE 12. Janice M. Mueller (2001), ‘No ‘’Dilettante Affair’’: Rethinking the Experimental Use Exception to Patent Infringement for Biomedical Research Tools’ PART VI THE ROLE OF SECRECY AND PHYSICAL EXCLUDABILITY 13. John P. Walsh, Wesley M. Cohen and Charlene Cho (2007), ‘Where Excludability Matters: Material Versus Intellectual Property in Academic Biomedical Research’ PART VII COMMERCIALIZATION OF PUBLICLY FUNDED RESEARCH 14. Richard Jensen and Marie Thursby (2001), ‘Proofs and Prototypes for Sale: The Licensing of University Inventions’ 15. Arti K. Rai and Rebecca S. Eisenberg (2003), ‘Bayh-Dole Reform and the Progress of Biomedicine’ PART VIII INTELLECTUAL PROPERTY AND CONSUMER ACCESS 16. Robert Cook-Deegan, Subhashini Chandrasekharan and Misha Angrist (2009), ‘The Dangers of Diagnostic Monopolies’ 17. Henry G. Grabowski, David B. Ridley and Kevin A. Schulman (2007), ‘Entry and Competition in Generic Biologics’ Name Index

Read more less

Book SynopsisThis thoughtful book explores how EU law treats serious disagreements about the development and use of a radically new technology like genetic modification. Relevant EU laws are examined to analyze the room available, or possible, for public participation in the EU regulation of GMOs.Since linkages between law, technology and public contestations could have a crucial dimension in the shaping of democratic societies, the space that EU law provides for publics (outside of the scientific experts who shape the regulation of GMOs) becomes significant. By examining the employment of the precautionary principle and (advice from) public bioethics committees in GMO regulation, this book examines the policy claim that public participation as a regulatory mechanism represents and mediates public contestations about the use and regulation of GMOs.Biotechnology Regulation and GMOs will be of great interest to researchers, academics, students, policy advisors, decision-makers and other professionals involved in the fields of law, biotechnology, innovation systems, science and technology policy, as well as development. Federal regulators and industry representatives will also find much to interest them in this detailed study.Contents: 1. Introduction 2. The EU Legal Framework for GMO Regulation 3. Risk, Science and Society 4. Precaution, Public Participation and Technocratic Responses 5. Participation in Safety and Public Morals Regulation Ambit in Global Rules 6. Public Contestations and Pursuit of Public Values IndexTrade Review‘In this sophisticated examination of the EU regulatory framework for GMOs, Naveen Thayyil identifies a worrying shortfall between the commitment to public participation and its implementation - a deficit that results in a failure fully to engage the public in debates that represent their concerns (whether about what is ‘safe’ or what is ‘right’). For anyone who senses that our technological futures are too important to be left to the ‘experts’, this is a book to be read.’ -- Roger Brownsword, King’s College London, UKTable of ContentsContents: 1. Introduction 2. The EU Legal Framework for GMO Regulation 3. Risk, Science and Society 4. Precaution, Public Participation and Technocratic Responses 5. Participation in Safety and Public Morals Regulation Ambit in Global Rules 6. Public Contestations and Pursuit of Public Values Index

Read more less

Book SynopsisThis book examines the important role of consumer activism in health policy in different national contexts. In an age of shifting boundaries between state and civil society, consumer groups are potentially drivers of democratization in the health domain. The expert contributors explore how their activities bring new dynamics to relations between service providers, the medical profession, government agencies, and other policy actors. This book is unique in comprehensively analyzing the opportunities and dilemmas of this type of activism, including ambiguous partnerships between consumer groups and stakeholders such as the pharmaceutical industry. These themes are explored within an internationally comparative framework, with case studies from various countries. Students and researchers in the fields of health policy and sociology, public policy and social movements will find this relevant and path-breaking book enlightening. It will also prove invaluable for participants and activists in patient and health consumer organizations.Contributors include: K. Adams, W. Armstrong, R. Baggott, R. Bal, S. Barraclough, G. Braunegger-Kallinger, J. Church, D. Delnoij, R. Edwards, R. Forster, M. Fox, B. Fredericks, J. Geissler, P.C. John, K. Jones, M. Koivusalo, K. Krajic, A. Lambertson, M. Leahy, D. Legge, H. Lofgren, T. Milewa, C. Nunez Daw, O. O'Donovan, K.-L. Phua, A. Schipaanboord, J. Tritter, D. Truong, P. Vaillancourt Rosenau, A. VitryTable of ContentsContents: 1. Introduction – Consumer Groups and the Democratization of Health Policy Michael Leahy, Hans Löfgren and Evelyne de Leeuw 2. Health Activism in the Age of Governance Timothy Milewa 3. Health Consumer Groups in the United Kingdom: Progress or Stagnation? Kathryn Jones and Rob Baggott 4. Citizens, Consumers and Stakeholders in European Health Policy Meri Koivusalo and Jonathan Tritter 5. The People’s Health Movement: Health for All, Now! Prem Chandran John and David G. Legge 6. Aboriginal Community Control and Decolonizing Health Policy: A Yarn from Australia Bronwyn Fredericks, Karen Adams and Rebecca Edwards 7. The Irish Health Service’s Expert Advisory Groups: Spaces for Advancing Epistemological Justice? Orla O’Donovan 8. Patient Empowerment in the Netherlands Atie Schipaanboord, Diana Delnoij and Roland Bal 9. Health Policy in Germany: Consumer Groups in a Corporatist Polity Jens Geissler 10. Austrian Health Consumer Groups: Voices Gaining Strength? Rudolf Forster, Gudrun Braunegger-Kallinger and Karl Krajic 11. Malaysia: The Consumer Voice in the Policy Process Simon Barraclough and Phua Kai Lit 12. From Activism to State Inclusion: Health Consumer Groups in Australia Hans Löfgren, Michael Leahy and Evelyne de Leeuw 13. Health Consumers in Canada: Swimming Against a Neo-liberal Tide John Church and Wendy Armstrong 14. Empowering Health Care Consumers in the United States Michael H. Fox and Anna Lambertson 15. Health Policy in the United States: Consumers and Citizens in a Market Polity Christina Nuñez Daw, Denise Truong and Pauline Vaillancourt Rosenau 16. Health Consumer Groups and the Pharmaceutical Industry: Is Transparency the Answer? Agnes Vitry and Hans Löfgren Index

Read more less

Book SynopsisIntellectual property rights (IPRs), particularly patents, occupy a prominent position in innovation systems, but to what extent they support or hinder innovation is widely disputed. Through the lens of biotechnology, this book delves deeply into the main issues at the crossroads of innovation and IPRs to evaluate claims of the positive and negative impacts of IPRs on innovation. An international group of scholars from a range of disciplines - economic geography, health law, business, philosophy, history, public health, management - examine how IPRs actually operate in innovation systems, not just from the perspective of theory but grounded in their global, regional, national, current and historical contexts. In so doing, the contributors seek to uncover and move beyond deeply held assumptions about the role of IPRs in innovation systems.Scholars and students interested in innovation, science and technology policy, intellectual property rights and technology transfer will find this volume of great interest. The findings will also be of value to decision makers in science and technology policy and managers of intellectual property in biotechnology and venture capital firms.Trade Review'. . . recommended to anyone interested in the thrilling subject of the relationship of IPRs and innovation.' -- Ralf Uhrich, Journal of Intellectual Property'This is an outstanding piece of scholarship. It will serve as a powerful stimulant for new research in the field and as a reliable guide for practitioners.' -- Calestous Juma, Harvard University, USTable of ContentsContents: Introduction David Castle PART I: INTELLECTUAL PROPERTY RIGHTS IN INNOVATION SYSTEMS 1. Introduction David Castle 1. Are Intellectual Property Rights Quanta of Innovation? J. Adam Holbrook 2. Intellectual Property Rights and Innovation Systems: Issues for Governance in a Global Context Bjørn Asheim, Finn Valentin and Christian Zeller 3. Intellectual Property Rights Policy for Gene-Related Inventions – Toward Optimum Balance Between Public and Private Ownership Koichi Sumikura PART II: INTELLECTUAL PROPERTY MANAGEMENT IN BIOTECHNOLOGY Introduction Karen L. Durell 4. Fundamentals of Intellectual Property Management Patrick H. Sullivan 5. Making a Return on R&D: A Business Perspective Sharon Oriel 6. Looking Beyond the Firm: Intellectual Asset Management and Biotechnology Karen L. Durell and E. Richard Gold PART III: INTELLECTUAL PROPERTY RIGHTS IN RELATION TO OTHER MEASURES OF INNOVATION Introduction L. Martin Cloutier and David Castle 7. Increasing Internal Value from Patents: The Role of Organizational Arrangements Marc Ingham, Cecile Ayerbe, Emmanuel Métais and Liliana Mitkova 8. Language System (LS) 3.0: An Agenda for a Model of Innovation Valuation Clinton W. Francis 9. Measurement of Innovation and Intellectual Property Management: Challenging Processes L. Martin Cloutier and Susanne Sirois PART IV: BEYOND PATENT LENGTH Introduction Amy J. Glass and Fabricio X. Nunez 10. Open Development: Is the ‘Open Source’ Analogy Relevant to Biotechnology? Alan G. Isaac and Walter G. Park 11. On the Border: Biotechnology, the Scope of Intellectual Property and the Dissemination of Scientific Benefits Christopher May 12. On the Comparative Institutional Economics of Intellectual Property in Biotechnology F. Scott Kieff PART V: INNOVATION GOVERNANCE Introduction Tania Bubela 13. Accessibility of Biological Data: A Role for the European Database Right? Jasper A. Bovenberg 14. Biotechnology Patents, Public Trust and Patent Pools: The Need for Governance? Timothy Caulfield 15. Agricultural Biotechnology and Trends in the Intellectual Property Rights Regime: Emerging Challenges for Developing Countries Sachin Chaturvedi PART VI: NATIONAL, INTERNATIONAL AND HISTORICAL COMPARISONS Introduction Abdallah S. Daar and David Castle 16. The Role of Intellectual Property Rights in Biotechnology Innovation: National and International Comparisons Richard Y. Boadi 17. Intellectual Property, Information and Divergences in Economic Development – Institutional Patterns and Outcomes circa 1421–2000 Ian Inkster 18. Watch What You Export: The History of Medical Exceptions from Patentability Tina Piper Index

Read more less

Book SynopsisStarting with the 13th century, this book explores how patents have been used as an economic protectionist tool, developing and evolving to the point where thousands of patents have been ultimately granted not over inventions, but over isolated or purified biological materials. DNA, invented by no man and once thought to be 'free to all men and reserved exclusively to none', has become cartelised in the hands of multinational corporations. The author questions whether the continuing grant of patents can be justified when they are now used to suppress, rather than promote, research and development in the life sciences.Luigi Palombi demonstrates that patents are about inventions and not isolated biological materials, which consequently have no bona fide purpose in the innovations of biotechnological science. This book will be important reading for anyone who has an interest in the role that patents have played in economic development - particularly historians, economists and scientists. It will also be of great interest to law academics, lawyers, judges and policymakers.Trade Review'Palombi has penned a strong critique of the abuse of the patent system by the biotech industry in its pursuit of monopoly rights over natural organisms and their parts and, in particular, over fragments of DNA. He argues that it is difficult to recognise such ownership as reflecting genuine novelty of human inventiveness. He shows through detailed exposition and analysis of cases how the patent system has been appropriated (in his words) to serve the interests of a narrow group of biotech, pharma and chemical interests; his book will serve as a clear statement as to why this is so damaging to real innovation and progress in a range of health-related topics.' -- John A. Mathews, Review of International Political Economy'It's really excellent: an invaluable source of information and highly readable too.' -- Sir John Sulston, University of Manchester, UK and Winner of the 2002 Nobel Prize in Physiology or Medicine'. . . this is a book that every policymaker even remotely connected to issues of patents, economics, and biotech should read. This book is essential ammunition for those who oppose gene patenting, and lays out the legal case expertly.' -- David Koepsell, Delft University of Technology, The Netherlands, reviewed in SCRIPTed'The book is of interest to judges, patent attorneys and lawyers and policy-makers in this field. . . The first part is a fascinating and well researched historical study of patenting. . . The second part of the book is interesting and the author raises some very important points. . . a very valuable contribution to the debate of the scope of patent monopolies.' -- David Rogers, Legal Member, Boards of Appeal, European Patent Office, Germany, reviewed in European Intellectual Property ReviewTable of ContentsContents: Foreword by Baruch S. Blumberg Preface Part I: Monopolies in the Age of Free Trade 1. The Early History of Anglo-American Patent Systems 2. Patents and their Use in Economic Warfare 3. Patent Monopolies versus Free Trade 4. The Patent Systems of Continental Europe 5. The Internationalization and Harmonization of the Patent Systems Part II: The Patenting of Biological Materials: The Monopolization of Nature 6. The Isolation Contrivance 7. Anything Under the Sun Made by Man 8. The Invention of Nature? 9. Gene Wars 10. Synthetic Biology and a Time for Reflection Bibliography Index

Read more less

Book SynopsisThis unique and comprehensive collection investigates the challenges posed to intellectual property by recent paradigm shifts in biology. It explores the legal ramifications of emerging technologies, such as genomics, synthetic biology, stem cell research, nanotechnology, and biodiscovery. Extensive contributions examine recent controversial court decisions in patent law - such as Bilski v. Kappos, and the litigation over Myriad's patents in respect of BRCA1 and BRCA2 - while other papers explore sui generis fields, such as access to genetic resources, plant breeders' rights, and traditional knowledge. The collection considers the potential and the risks of the new biology for global challenges - such as access to health-care, the protection of the environment and biodiversity, climate change, and food security. It also considers Big Science projects - such as biobanks, the 1000 Genomes Project, and the Doomsday Vault. The inter-disciplinary research brings together the work of scholars from Australia, Canada, Europe, the UK, and the US and involves not only legal analysis of case law and policy developments, but also historical, comparative, sociological, and ethical methodologies. Intellectual Property and Emerging Technologies will appeal to policy makers, legal practitioners, business managers, inventors, scientists, and researchers. Contributors include: A. Agovic, A. Bostanci, J. Calvert, G. Dutfield, D.M. Gitter, R. Gold, F. Hemmings, E. Hemmungs Wirten, S. Holcombe, T. Janke, P.-B. Joly, Y. Joly, A. McLennan, D. Nicol, M. Rimmer, J.D. SarnoffTable of ContentsContents: Preface Introduction: Inventing Life: Intellectual Property and the New Biology Alison McLennan and Matthew Rimmer PART I: A HISTORY OF BIODISCOVERY 1. Of Plants, Pills and Patents: Circulating Knowledge Eva Hemmungs Wirtén PART II: MEDICINE, BIOTECHNOLOGY AND GENOMICS 2. Bilski v. Kappos and Biotechnology Patents: Back to the Future? Yann Joly and Francis Hemmings 3. The Current State of Patent Eligibility of Medical and Biotechnology Inventions in the United States Joshua D. Sarnoff 4. Patent Law, the Emerging Biotechnologies and the Role of Language in Subject-Matter Expansionism Graham Dutfield PART III: BIOBANKS, BIOINFORMATICS AND BIOBRICKS 5. Standards for Biobank Access and Intellectual Property Dianne Nicol and Richard Gold 6. The 1000 Genomes Project Donna M. Gitter 7. Building with BioBricks: Constructing a Commons for Synthetic Biology Research Alison McLennan PART IV: GENETICS, STEM CELLS AND NANOTECHNOLOGY 8. Regulating Gene Regulation: Patenting Small RNAs Adam Bostanci, Jane Calvert and Pierre-Benoit Joly 9. Stem Cell Patents: Looking for Serenity Amina Agovic 10. Cosmo, Cosmolino: Patent Law and Nanotechnology Alison McLennan and Matthew Rimmer PART V: BIODIVERSITY, FOOD SECURITY AND CLIMATE CHANGE 11. Patenting the Kakadu Plum and the Marjarla Tree: Biodiscovery, Intellectual Property and Indigenous Knowledge Sarah Holcombe and Terri Janke 12. Climate-Ready Crops: Intellectual Property, Agriculture and Climate Change Matthew Rimmer 13. The Doomsday Vault: Seed Banks, Food Security and Climate Change Matthew Rimmer Bibliography Index

Read more less

Book SynopsisIn this thought-provoking book, leading experts explore why international entrepreneurship is important to the life sciences industry. From multi-disciplinary and cross-national perspectives, they question why international entrepreneurship scholars might usefully invest interest in research focused on one specific industry context. The book addresses contemporary challenges of relevance to life science firms and draws on leading-edge debates in international entrepreneurship research. Topics include: the nature of the born-global firm; the development of international capabilities and competencies; the role of local and international partnerships and alliances; competitiveness, opportunity recognition and orientation; and the role of specialized complementary assets in internationalization. It concludes by proposing an agenda for future research across the underpinning fields of innovation, entrepreneurship and internationalization. This book will prove a stimulating read for academics, students and researchers with an interest in international business, management and entrepreneurship, as well as for practitioners in the health professions or life sciences academics who are, or may become, entrepreneurs.Trade Review'The processes of internationalization, innovation and venture-creation in high-technology new ventures are inextricably intertwined. This is particularly true in the uncertain and troubled waters of the life sciences industry where startups with very uncertain futures are required to face significant challenges in short windows of opportunity. Navigating these waters is not straightforward, neither for those immediately involved in it, nor for those trying to understand it. This book is a must-read for anyone who is serious about understanding entrepreneurship in the biotechnology industry.' --- Alberto Onetti, CrESIT (Research Center for Innovation and Life Science Management), ItalyTable of ContentsContents: Introduction: International Entrepreneurship in the Life Sciences Marian V. Jones, Colin Wheeler and Pavlos Dimitratos PART I: NEW VENTURE ATTRIBUTES AND DEVELOPMENT CAPABILITIES 2. Assessing the Internationalization Capabilities of Life Science New Ventures Marian V. Jones, Colin Wheeler, Pavlos Dimitratos and George Vlachos 3. Differences in the Strategic Orientations of Nordic and US-based Young Biotechnology Ventures Maija Renko 4. Small Pharmaceutical Firms Building Capabilities to Compete Along the Global Research and Development Pipeline Lisette Pregelj, Martie-Louise Verreynne and Damian Hine PART II: THE ROLE AND ESTABLISHMENT OF PARTNERSHIPS 5. Partnership Formation in Small Biotech Companies Niina Nummela and Outi Nurminen 6. Collaborative Entrepreneurship and Internationalization in Life Sciences: Global Growth through Collaboration in Italian Biotech Firms Antonella Zucchella and Diala Kabbara 7. Alliance-driven Governance in the Scottish Life Sciences and its Contribution to Regional Development Kean Birch and Andrew Cumbers PART III: DEVELOPING CAPABILITIES AND COMPETENCIES FOR INTERNATIONALIZATION 8. Sub-suppliers in the Life Science Industry: The Case of Two Danish University Spin-offs Erik S. Rasmussen, Martin Hannibal, René Lydiksen and Per Servais 9. Rapid Internationalization and Sustained Competitive Advantage in US and UK Life Science International New Ventures: A Resource-based View Karl Warner and Jon Carrick 10. Intellectual Property Protection: The Case of Three Swiss Life Science SMEs Marcus Matthias Keupp, Sascha Friesike and Oliver Gassmann PART IV: GROWTH, PERFORMANCE AND INTERNATIONALIZATION 11. Performance Trade-offs: Success, Revenue and Profitability Colin Wheeler, Marian V. Jones, George Vlachos and Pavlos Dimitratos 12. Internationalization of Life Science Firms: Dynamics in the Interaction between Networks, Innovation and Export Performance Vandana Ujjual 13. Firm Growth and Performance in Biotechnology: Financial Facts or Wishful Thinking? Malin Brännback, Alan L. Carsrud and Niklas Kiviluoto 14. A Model of Decision-making Processes in Internationalized Life Science Firms Pavlos Dimitratos, Marian V. Jones and Colin Wheeler 15. Towards a Research Agenda for International Entrepreneurship in the Life Sciences Marian V. Jones, Colin Wheeler and Pavlos Dimitratos References Index

Read more less

Book SynopsisNew technologies will have an increasing effect on prospects for development and growth in the world economy. Technology and Innovation in the International Economy contains extensive and detailed assessments of two key areas of technological innovation which present both a threat and an opportunity for developing countries: microelectronics and biotechnology.The two major review essays - Jeffrey James on microelectronic technology and Martin Fransman on biotechnology - assess the impact of these new technologies on production, trade, employment and welfare in developing countries. The introduction by Charles Cooper deals with recent advances in the economics of innovation and diffusion of new technologies, and attempts to build a bridge between the study of technology in the industrial sectors of developed countries and the type of technology policy needed in the developing countries.Policymakers, researchers and students will welcome the clarity and breadth of this important volume which contains much original analysis and detailed information on a major issue confronting developing and developed nations alike.Trade Review’This book provides a valuable discussion of the existing literature on technology and innovation, both theoretical and empirical, drawing lines for its relevance to the Third World and about future research agenda in these areas.’Table of ContentsForeward - Charles Cooper. 1. Relevance of innovation studies to developing countries - Charles Cooper. 1. I Introduction. 1.2 Innovation and technological change. 1.3 Implications for developing countries. 1.4 Concluding remarks. Acknowledgements. Notes. References. 2. Biotechnology: Generation, diffusion, and policy - Martin Fransman. 2.1 Introduction. 2.2 The generation of biotechnology: invention and innovation. 2.3 Economic effects of biotechnology 2.4 Implications for the third world. 2.5 Recent additions to the literature. 2.6 Towards a general research agenda. Acknowledgements. Notes. References. Annotated bibliography. For further reading. 3. Microelectronics and the Third World - Jeffrey James. 3. 1 Introduction. 3.2 Patterns of adoption and diffusion in the Third World 3.3 Impacts of microelectronics. 3.4 Policy implications and future research directions. Acknowledgements. Notes. References. For further reading.

Read more less

Book SynopsisThe development of modern biotechnology has varied considerably from country to country. Typically, there are wide technology gaps between developing and industrialised countries and considerable differences in investment and regulatory systems, often creating a need for policy intervention. This innovative book examines the development and evolution of biotechnology in industrialised and developing countries. The author first explores efforts made by policymakers and the leaders in the field to reduce technology gaps, and analyses the development of financial mechanisms and regulatory frameworks to hasten the adoption and diffusion of biotechnology. The second section looks at the relationship between biotechnology and its resource base, biological diversity. The author emphasizes the interdependency between biodiversity and biological R&D in an attempt to simplify the debate on the conservation of biological diversity. The last section focuses on the potential positive and negative impacts of biotechnology and its contribution towards sustaining biodiversity.The Emergence and Growth of Biotechnology will be of great interest to undergraduate and postgraduate economics students interested in the economics of technology, economic development and biotechnology and environmental conservation.Trade Review'Acharya employs specific descriptions and concise writing to explain fully the commercial and environmental concerns that are relevant to the global expansion of biotechnology. The Emergence and Growth of Biotechnology offers a brilliant survey of the field. . . This book is ideal for the reader who seeks a strong basic knowledge of the biotechnology market.' -- Journal of International Law and Politics'. . . this book would greatly benefit the students of economics, scientists, and policymakers alike.'– Parvinder Chawla, Journal of Scientific and Industrial ResearchTable of ContentsContents: 1. Introduction Part I: Biotechnology and its Development 2. The Development of Biotechnology 3. From Human Insulin to Oncomice: Patterns of Innovation in Industrialised Countries 4. Biotechnology in Developing Countries 5. The Impact of Biotechnology on International Trade Part II: Biotechnology and Biodiversity 6. Biotechnology and Biodiversity: The Links 7. The Conservation and Sustainable Utilisation of Biodiversity: The Role of Biotechnology and Bioprospecting 8. Concluding Remarks References Index

Read more less

Book SynopsisWhen a patient is brought into a trauma centre in extremis, or becomes that way during a hospital stay, the intervention mantra is airway, breathing and circulation - the ABC's. This book provides the nonspecialist physician, and those in the participating and supporting professions, with a quick overview of the meaning of the testing terms in this environment. Many tests, added singly or in small groups over time as clinical and measurement technology evolved, but whose rationale may have become less clear, are defined and explained.The format here is simple - a brief overview of the physiologic environment and then the encyclopedic dictionary of the terminology. Included are common terms as well as some of the confusing uses of terms, besides lesser known facts influencing their clinical use on the basis of the analytical, medical, and managerial experience of the authors.

Read more less

Book SynopsisThis volume contains the proceedings of the RAAD 2018 conference, covering major areas of research and development in robotics. It provides an overview on the advances in robotics, more specifically in novel design and applications of robotic systems; dexterous grasping, handling and intelligent manipulation; intelligent cooperating and service robots; advanced robot control; human-robot interfaces; robot vision systems and visual serving techniques; mobile robots; humanoid and walking robots; field and agricultural robotics; bio-inspired and swarm robotic systems; developments towards micro and nano-scale robots; aerial, underwater and spatial robots; robot integration in holonic manufacturing; personal robots for ambient assisted living; medical robots and bionic prostheses; intelligent information technologies for cognitive robots etc. The primary audience of the work are researchers as well as engineers in robotics and mechatronics. Table of Contents

Read more less

Book SynopsisThis textbook teaches bioengineers critical concepts about protein three dimensional structures, how proteins fold, and how the folding affects the functioning of the protein. Protein folding has profound effects on the discovery of biopharmaceutical drugs (especially the transport of immunological compounds to their site of action) as well as on tissue engineering. Dr. Dods covers topics in easily understood terms through the use of glossaries heading each chapter and footnotes and summaries at the end of each chapter. The chapters cover disordered proteins and large sequences of disorder that exists within proteins, secondary structure (α-helix and β-pleated structure), tertiary and quaternary structure, post-translational changes, proteopathies, bioengineering approaches used to study protein folding, and computer software for protein folding. For each of these topics the elements of biomolecular imaging, cellular and tissue engineering, and health care systems engineering are built. Molecular engineering concepts such as site-directed mutagenesis are addressed. For reinforcement of the concepts presented in this text, activities and problems (Queries) are included in the chapter. Table of ContentsPreface.- Primary Structure.- Secondary Structure.- Tertiary Structure.- Quaternary Structure.- Post-Translational Changes.- Proteopathies.- Unusual Proteins.- Techniques Used to Study Protein Folding.- Software for Protein Folding.- Bioengineering.- Postscript.

Read more less

Book SynopsisThe population of the world continues to increase at an alarming rate. The trouble linked with overpopulation ranges from food and water scarcity to inadequacy of space for organisms. Overpopulation is also linked with several other demographic hazards, for instance, population blooming will not only result in exhaustion of natural repositories, but it will also induce intense pressure on the world economy. Today nanotechnology is often discussed as a key discipline of research but it has positive and negative aspects. Also, due to industrialization and ever-increasing population, nano-pollution has been an emerging topic among scientists for investigation and debate. Nanotechnology measures any substance on a macromolecular scale, molecular scale, and even atomic scale. More importantly, nanotechnology deals with the manipulation and control of any matter at the dimension of a single nanometer. Nanotechnology and nanoparticles (NPs) play important roles in sustainable development and environmental challenges as well. NPs possess both harmful and beneficial effects on the environment and its harboring components, such as microbes, plants, and humans. There are many beneficial impacts exerted by nanoparticles, however, including their role in the management of waste water and soil treatment, cosmetics, food packaging, agriculture, biomedicines, pharmaceuticals, renewable energies, and environmental remedies. Conversely, NPs also show some toxic effects on microbes, plants, as well as human beings. It has been reported that use of nanotechnological products leads to the more accumulation of NPs in soil and aquatic ecosystems, which may be detrimental for living organisms. Further, toxic effects of NPs on microbes, invertebrates, and aquatic organisms including algae, has been measured. Scientists have also reported on the negative impact of NPs on plants by discussing the delivery of NPs in plants. Additionally, scientists have also showed that NPs interact with plant cells, which results in alterations in growth, biological function, gene expression, and development. Thus, there has been much investigated and reported on NPs and plant interactions in the last decade. This book discusses the most recent work on NPs and plant interaction, which should be useful for scientists working in nanotechnology across a wide variety of disciplines.Table of Contents1. Applications of Nanomaterials to Enhance Plant Health and Agricultural Production2. Nanoparticles and their impacts on seed germination3. Synthesis and characterization of zinc oxide nanoparticles and their impact on plants4. Physiology of zinc oxide nanoparticles in plants5. Effect of TiO2 as plant-growth stimulating nanomaterial on crop production6. Contribution to monography Nanomaterials and physiological and biochemical responses of plants7. Impacts of Carbon nanotubes on physiology and biochemistry of plants8. Silver Nanoparticles and their Morpho-physiological Responses on Plants9. Nanoparticles: Sources and toxicity10. Impact of cobalt nanoparticles on morpho-physiological and biochemical responses of plants11. Nanoparticles-induced oxidative stress in plants12. Variability, behaviour and impact of nanoparticles in the environment

Read more less

Book SynopsisSocial Emergency Medicine incorporates consideration of patients’ social needs and larger structural context into the practice of emergency care and related research. In doing so, the field explores the interplay of social forces and the emergency care system as they influence the well-being of individual patients and the broader community. Social Emergency Medicine recognizes that in many cases typical fixes such as prescriptions and follow-up visits are not enough; the need for housing, a safe neighborhood in which to exercise or socialize, or access to healthy food must be identified and addressed before patients’ health can be restored. While interest in the subject is growing rapidly, the field of Social Emergency Medicine to date has lacked a foundational text – a gap this book seeks to fill. This book includes foundational chapters on the salience of racism, gender and gender identity, immigration, language and literacy, and neighborhood to emergency care. It provides readers with knowledge and resources to assess and assist emergency department patients with social needs including but not limited to housing, food, economic opportunity, and transportation. Core emergency medicine content areas including violence and substance use are covered uniquely through the lens of Social Emergency Medicine. Each chapter provides background and research, implications and recommendations for practice from the bedside to the hospital/healthcare system and beyond, and case studies for teaching. Social Emergency Medicine: Principles and Practice is an essential resource for physicians and physician assistants, residents, medical students, nurses and nurse practitioners, social workers, hospital administrators, and other professionals who recognize that high-quality emergency care extends beyond the ambulance bay.Table of ContentsHistory of Social Emergency MedicinePublic Health, Population Health, and Health DisparitiesRace and RacismGender and Sexual IdentityImmigrationLanguage and LiteracyAccess to CareFrequent Emergency Department Use: A Social Emergency Medicine PerspectiveSubstance Use: A Social Emergency Medicine PerspectiveEducation and EmploymentFinancial InsecurityFood InsecurityHomelessnessHousing Instability and QualityTransportationLegal NeedsNeighborhoods and the Built EnvironmentViolenceFirearm InjuryIncarcerationHuman Trafficking.

Read more less

Book SynopsisThis book is the first comprehensive compilation of deliberations on whole genome sequencing of the diploid and tetraploid alfalfa genomes including sequence assembly, gene annotation, and comparative genomics with the model legume genome, functional genomics, and genomics of important agronomic characters. Other chapters describe the genetic diversity and germplasm collections of alfalfa, as well as development of genetic markers and genome-wide association and genomic selection for economical important traits, genome editing, genomics, and breeding targets to address current and future needs. Altogether, the book contains about 300 pages over 16 chapters authored by globally reputed experts on the relevant field in this crop. This book is useful to the students, teachers, and scientists in the academia and relevant private companies interested in genetics, breeding, pathology, physiology, molecular genetics and breeding, biotechnology, and structural and functional genomics. The work is also useful to seed and forage industries.Table of Contents

Read more less